Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019050	s-ttgaba	— (—)	74892	94280	100.00%	Distribution not available
3019050	s-ttgaba	u/ml (u/ml)	23502	27796	0.04%
3019050	s-ttgaba	eliau/ml (u/ml)	2579	2712	0.00%
3019050	s-kudostransglutaminaasi,igavasta-aineet	— (—)	535	547	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,igavasta-aineet	u/ml (u/ml)	450	463	0.00%
3019050	s-kudostransglutaminaasi,iga-vasta-aineet	— (—)	217	222	100.00%	Distribution not available
3019050	kudostransglutaminaasi,igavasta-aineet	u/ml (u/ml)	68	69	0.00%
3019050	s-ttgaba,s-kudostransglutaminaasi,igavasta-aineet	— (—)	52	54	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,iga-vasta-aineet	u/ml (u/ml)	23	23	0.00%
3019050	kudostransglutaminaasi,igavasta-aineet	— (—)	22	22	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic gastritis

3487

18357

2.23

321.65

1.3

1.2

2.50

1.74

u/ml

1.12

617

4830

Diseases of the musculoskeletal system and connective tissue

9866

33257

1.64

319.99

1.3

1.56

2.01

u/ml

2.52

2729

9029

Nerve, nerve root and plexus disorders

15008

69205

1.47

315.75

1.3

1.60

1.67

u/ml

0.29

4174

18945

Diaphragmatic hernia

4653

27078

2.00

314.94

1.3

1.2

1.50

1.68

u/ml

0.44

1047

7092

Other and unspecified anaemias

4884

27672

1.94

314.14

1.4

1.3

1.80

u/ml

0.00

1077

7079

Other anaemias

4931

27966

1.93

312.91

1.4

1.3

1.81

1.79

u/ml

0.02

1089

7137

Sub-endpoint used in defining T1D endpoints

5996

24820

3.23

307.65

2.0

1.3

2.10

1.82

u/ml

0.79

1866

6671

Recurrent or chronic depression

7793

28629

2.41

307.65

1.4

1.2

1.21

1.96

u/ml

7.27

2051

8345

Anaemias

5260

13927

3.38

307.65

1.4

1.2

2.04

2.00

u/ml

0.06

1405

4100

Disorders of thyroid, IBD co-morbidities

3142

10682

2.60

307.65

1.4

1.2

1.65

2.05

u/ml

0.89

853

3011

Opioids

16108

61048

1.50

307.65

1.3

1.48

1.74

u/ml

1.69

4356

17210

Other antidepressants

17592

57158

1.81

307.65

1.3

1.39

1.89

u/ml

5.66

4650

15973

Type 1 diabetes, wide definition, subgroup 1

5383

18949

4.76

307.65

2.0

1.3

2.10

1.89

u/ml

0.48

1698

5164

Constipation

13715

58674

1.93

307.65

1.3

1.28

1.77

u/ml

5.69

3383

15775

Spondylopathies

10669

43914

1.61

307.65

1.3

1.2

1.34

1.90

u/ml

4.90

3080

11819

Neurological diseases, wide definition

6273

17280

2.11

307.65

1.4

1.2

1.72

2.19

u/ml

1.46

1739

4695

Sleep disorders (combined)

14444

68092

1.52

307.65

1.3

1.35

1.77

u/ml

4.55

4012

18550

Psychiatric diseases

17060

62555

1.48

307.65

1.3

1.60

1.79

u/ml

1.04

4402

17529

First line medication for Crohn's disease

17561

70893

1.46

307.65

1.3

1.35

1.82

u/ml

5.83

4638

19595

Other soft tissue disorders, not elsewhere classified

15498

61286

1.77

307.65

1.3

1.40

1.81

u/ml

3.75

4049

16759

Shoulder lesions

10563

43833

1.62

307.65

1.3

1.2

1.47

1.80

u/ml

2.07

3038

12049

Asthma, excluding more controls

12603

45463

1.63

307.65

1.3

1.45

1.83

u/ml

2.62

3472

12855

Neurotic, stress-related and somatoform disorders

15464

71457

1.75

307.65

1.4

1.3

1.39

1.73

u/ml

2.77

3955

20042

Disorders of the thyroid gland

15089

66901

1.64

307.65

1.4

1.3

1.45

1.67

u/ml

1.52

4386

17908

Spondylosis

6766

35764

1.82

307.65

1.3

1.2

1.27

1.94

u/ml

5.66

2027

9425

Type 1 diabetes, wide definition

5489

20019

4.37

307.65

2.0

1.3

2.15

1.88

u/ml

0.70

1727

5440

Anxiety disorders, excluding more controls

14355

59910

1.82

307.65

1.4

1.3

1.38

1.77

u/ml

3.25

3672

17020

Oral corticosteroids

15991

69647

1.51

307.65

1.3

1.29

1.78

u/ml

6.78

4364

19169

Follow-up examination after treatment for conditions other than malignant neoplasms

6916

28198

1.80

307.65

1.3

1.2

2.17

1.65

u/ml

1.38

1414

8137

Osteoporosis

3365

16667

2.35

307.65

1.4

1.2

1.20

1.75

u/ml

2.81

988

4024

Other diseases of urinary system

15630

64172

1.49

307.65

1.3

1.54

1.68

u/ml

0.71

4199

17462

Benign neoplasm: Colon

6494

29035

1.98

307.65

1.3

1.2

1.64

1.68

u/ml

0.08

1501

7916

Mood disorders, excluding more controls

16252

62219

1.81

307.65

1.3

1.37

1.76

u/ml

3.59

4091

17597

Functional dyspepsia

4250

21789

2.43

307.65

1.4

1.2

1.26

1.68

u/ml

2.07

1025

6074

GASTRO-related operations

14753

49133

1.67

307.65

1.3

1.51

1.73

u/ml

1.33

3756

14451

Parasetamol

13790

47294

1.64

307.65

1.3

1.42

1.92

u/ml

4.79

3981

12735

Diabetes mellitus

15822

67072

1.54

307.65

1.5

1.2

1.78

1.71

u/ml

0.25

4546

18292

Nutritional anaemias

6796

38238

2.01

307.65

1.4

1.3

2.08

1.69

u/ml

1.24

1721

10021

Diseases of the digestive system

6716

35882

2.23

307.65

1.7

1.3

7.67

1.22

u/ml

64.78

2200

9136

Type 1 diabetes

5924

22594

3.94

307.65

2.0

1.3

2.09

1.85

u/ml

0.66

1838

6141

Benign neoplasm of colon, rectum, anus and anal canal

7977

41373

2.01

307.65

1.3

1.2

1.77

1.70

u/ml

0.14

1818

10815

Autoimmune diseases excluding thyroid diseases, strict definition

18486

59634

2.00

307.65

1.5

1.2

3.29

1.23

u/ml

37.28

5318

15659

Diseases of liver

5047

26001

2.39

307.65

1.4

1.3

1.77

1.73

u/ml

0.06

1071

7048

Endocrine, nutritional and metabolic diseases

15424

48955

1.82

307.65

1.4

1.2

1.73

1.82

u/ml

0.35

4372

13359

Sciatica+with lumbago

7177

43404

1.77

307.65

1.3

1.33

1.83

u/ml

3.00

2129

11866

Gastro-oesophageal reflux disease

10811

53716

2.10

307.65

1.4

1.3

1.65

1.67

u/ml

0.04

2605

14895

Lower back pain or/and sciatica

16213

76645

1.63

307.65

1.3

1.36

1.74

u/ml

3.76

4627

20814

Diabetes medication

15703

67563

1.55

307.65

1.5

1.2

1.79

1.71

u/ml

0.32

4462

18416

Dorsalgia

16780

60855

1.66

307.65

1.3

1.42

1.85

u/ml

4.07

4806

16563

Other noninfective gastroenteritis and colitis

4054

21102

2.42

307.65

1.5

1.3

1.32

1.88

u/ml

2.57

1027

5575

Other diseases of liver

2799

13307

2.76

307.65

1.4

1.3

1.57

1.78

u/ml

0.28

606

3669

Diabetes, varying definitions

15615

66778

1.52

307.65

1.5

1.2

1.78

1.71

u/ml

0.25

4469

18206

Diseases of the skin and subcutaneous tissue

16639

58785

1.55

307.65

1.3

1.77

1.69

u/ml

0.27

4438

16271

Mood [affective] disorders

17680

74561

1.77

307.65

1.4

1.3

1.41

1.74

u/ml

2.76

4457

20839

Pain in limb

12282

57687

1.73

307.65

1.3

1.58

1.78

u/ml

0.89

3135

15743

Anxiety disorders

15556

71870

1.75

307.65

1.4

1.3

1.38

1.75

u/ml

3.16

3983

20131

Iron deficiency anaemia

5912

33033

2.10

307.65

1.4

1.3

1.98

1.68

u/ml

0.84

1532

8686

Other dorsopathies, not elsewhere classified

17000

61340

1.61

307.65

1.3

1.44

1.85

u/ml

3.78

4784

16665

Dorsopathies

16958

62011

1.52

307.65

1.3

1.37

1.86

u/ml

5.59

4780

16781

Other intervertebral disc disorders

11951

50853

1.57

307.65

1.3

1.52

1.84

u/ml

1.98

3204

13957

Other and unspecified dermatitis

7375

46855

1.80

307.65

1.4

1.3

1.56

1.62

u/ml

0.18

2081

12682

Other and unspecified iron deficiency

4927

25671

2.36

307.65

1.4

1.3

2.05

1.69

u/ml

0.93

1293

6784

Type1 diabetes, definitions combined, early onset

2005

7402

5.74

307.65

2.4

1.4

2.55

1.95

u/ml

0.85

574

1921

General symptoms and signs

18628

63958

1.61

307.65

1.3

1.43

1.83

u/ml

4.45

5125

17601

Cystitis

13655

58089

1.59

307.65

1.3

1.54

1.63

u/ml

0.38

3784

15761

Any gastric operation

14753

49133

1.67

307.65

1.3

1.51

1.73

u/ml

1.33

3756

14451

Anxiety (asthma-related co-morbidities)

11022

52985

1.93

307.65

1.4

1.3

1.35

1.74

u/ml

2.74

2751

15481

Asthma

12827

46830

1.62

307.65

1.3

1.44

1.85

u/ml

3.03

3533

13217

Hypothyroidism, other/unspecified

14245

63550

1.65

307.65

1.4

1.3

1.45

1.63

u/ml

1.06

4185

17034

Hypothyreosis and Thyroxine purchase for inclusion criteria

14609

66090

1.62

307.65

1.4

1.3

1.45

1.62

u/ml

1.04

4293

17685

Diverticular disease of intestine

10027

35957

2.14

307.65

1.3

1.2

1.41

1.84

u/ml

2.64

2418

9812

Other headache syndromes

6936

42065

1.93

307.65

1.3

1.27

1.73

u/ml

2.75

1893

11643

Tramadol

11515

50000

1.63

307.65

1.3

1.47

1.77

u/ml

1.49

2885

14127

Codeine

15485

59401

1.57

307.65

1.3

1.50

1.72

u/ml

1.33

4085

16799

Type 1 diabetes, definitions combined

2866

9917

5.58

307.65

2.2

1.3

2.31

1.87

u/ml

0.80

858

2634

Symptoms and signs involving the circulatory and respiratory systems

17697

60244

1.63

307.65

1.3

1.54

1.79

u/ml

1.70

4844

16734

Asthma (mode)

12698

47107

1.64

307.65

1.3

1.43

1.85

u/ml

3.18

3531

13291

Soft tissue disorders

17163

62777

1.55

307.65

1.3

1.47

1.81

u/ml

3.04

4708

17159

Low back pain

11956

57686

1.82

307.65

1.3

1.34

1.83

u/ml

4.72

3365

15749

Any reimbursement code in KELA

11080

38201

1.61

307.65

1.4

1.2

1.58

1.85

u/ml

1.36

3077

10771

Depression or dysthymia

12008

37934

2.04

307.65

1.3

1.40

2.00

u/ml

5.15

3218

10538

Diseases of oesophagus, stomach and duodenum

18000

66685

1.88

307.65

1.4

1.3

1.75

1.65

u/ml

0.41

4474

18761

Symptoms and signs involving the digestive system and abdomen

17356

54624

1.78

307.65

1.3

1.55

1.91

u/ml

3.04

4669

14938

Episodal and paroxysmal disorders

18598

66876

1.56

307.65

1.3

1.29

1.85

u/ml

9.07

5065

18068

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6791

19654

1.94

307.65

1.3

1.50

2.12

u/ml

3.27

1849

5633

Pain in throat and chest

13678

54820

1.70

307.65

1.3

1.46

1.81

u/ml

2.54

3528

15292

Hypothyroidism (congenital or acquired)

5809

15740

2.63

307.65

1.4

1.2

1.58

1.99

u/ml

1.47

1835

4703

Depression

16760

72844

1.82

307.65

1.4

1.3

1.38

1.74

u/ml

3.23

4230

20424

Autoimmune diseases

20744

61802

1.98

307.65

1.5

1.2

2.68

1.24

u/ml

27.06

6064

16176

Examination and observation for other reasons

11223

34102

2.41

307.65

1.4

1.2

2.09

1.76

u/ml

1.14

2636

9817

Depression medications

6574

16973

2.32

307.65

1.3

1.2

1.51

1.96

u/ml

1.69

1819

5061

Pain in joint

10545

36272

2.29

307.65

1.4

1.3

1.53

1.99

u/ml

2.53

2683

9962

Collagenous colitis

1603

6343

3.85

307.65

1.4

1.3

1.24

1.63

u/ml

0.75

426

1669

Benign neoplasm of colon, rectum, anus and anal canal

7610

31977

1.96

307.65

1.3

1.2

1.80

1.65

u/ml

0.33

1754

8863

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

14609

60511

1.63

307.65

1.5

1.2

1.81

1.75

u/ml

0.17

4163

16380

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

14689

71553

1.63

307.65

1.4

1.3

1.88

1.65

u/ml

1.14

3688

19622

Type 1 diabetes, strict (exclude DM2)

2857

9849

5.65

307.65

2.2

1.3

2.32

1.87

u/ml

0.80

855

2609

Insulin, combination of fast acting with intermediate-acting or long-acting

9537

47604

2.19

307.65

1.7

1.2

1.87

1.77

u/ml

0.32

2846

12420

Asthma, including avohilmo

18200

78166

1.46

307.65

1.3

1.48

1.77

u/ml

2.33

5047

21123

Other diseases of hard tissues of teeth

9857

48384

1.70

307.65

1.3

1.56

1.85

u/ml

1.40

2553

13597

Hypothyroidism, strict autoimmune

12075

49310

1.84

307.65

1.4

1.2

1.47

1.17

u/ml

2.25

3612

12977

Asthma (only as main-diagnosis)

11377

46830

1.62

307.65

1.3

1.47

1.85

u/ml

2.56

3179

13217

Mood disorders

17696

74609

1.77

307.65

1.4

1.3

1.41

1.74

u/ml

2.83

4462

20846

Hypothyroidism and >3 levothyroxin purchases

5769

15641

2.63

307.65

1.4

1.2

1.57

1.97

u/ml

1.45

1822

4682

Selective serotonin reuptake inhibitors

16479

57697

1.66

307.65

1.3

1.31

1.90

u/ml

7.78

4267

16051

Pain (limb, back, neck, head abdominally)

12209

37870

1.79

307.65

1.3

1.66

2.03

u/ml

2.13

3269

10315

Autoimmune diseases excluding thyroid diseases

19007

61114

2.00

307.65

1.5

1.2

3.26

1.23

u/ml

37.93

5461

16026

Diabetes, insulin treatment (Kela reimbursement)

15000

63025

1.60

307.65

1.5

1.2

1.78

1.76

u/ml

0.08

4268

17004

Abnormalities of breathing

14708

59878

1.61

307.65

1.3

1.57

1.79

u/ml

1.08

4017

16623

Dermatitis and eczema

18203

78076

1.72

307.65

1.3

1.65

1.72

u/ml

0.29

4904

21239

Asthma (only as main-diagnosis), excluding more controls

11235

45463

1.63

307.65

1.3

1.46

1.83

u/ml

2.41

3146

12855

Hypothyroidism, levothyroxine purchases

5769

15641

2.63

307.65

1.4

1.2

1.57

1.97

u/ml

1.45

1822

4682

Persons encountering health services in other circumstances, wide

18990

71173

1.50

307.65

1.3

1.63

1.77

u/ml

0.75

5364

19044

Persons encountering health services for other counselling and medical advice, not elsewhere classified

17516

70952

1.54

307.65

1.3

1.73

1.76

u/ml

0.09

5007

18994

Hypothyroidism, strict autoimmune, 3 medication purchases required

12971

62573

1.56

307.65

1.4

1.3

1.42

1.59

u/ml

1.01

3848

16783

Autoimmune diseases related-to ILD

13302

77990

1.68

307.65

1.3

1.52

1.70

u/ml

0.92

3499

21429

Abdominal and pelvic pain

17371

54611

1.79

307.65

1.3

1.58

1.91

u/ml

2.33

4667

14936

Other diseases of intestines

19543

66954

1.97

307.65

1.3

1.51

1.82

u/ml

2.61

5175

18632

Insulin, fast-acting (human)

3332

12216

4.29

307.65

1.9

1.2

2.19

1.60

u/ml

1.46

1083

3405

Other special examinations and investigations of persons without complaint or reported diagnosis

11292

34333

1.86

307.65

1.4

1.2

1.64

1.77

u/ml

0.47

3167

9876

Noninfective enteritis and colitis

7633

44871

2.01

307.65

1.4

1.3

1.29

1.77

u/ml

3.56

1945

12280

Type 1 diabetes, strict definition, subgroup 1

2410

7929

6.80

307.65

2.3

1.3

2.37

1.89

u/ml

0.76

725

2139

Medical observation and evaluation for suspected diseases and conditions

11373

34333

1.91

307.65

1.3

1.2

1.85

1.77

u/ml

0.24

2756

9876

Other specific joint derangements/joint disorders

12607

55376

1.73

307.65

1.4

1.3

1.56

1.79

u/ml

1.02

3357

15262

Type 1 diabetes, strict definition

2503

8381

6.45

307.65

2.3

1.3

2.48

1.89

u/ml

1.02

748

2251

Gastrointestinal diseases

11675

33333

2.01

307.65

1.4

1.2

1.97

1.38

u/ml

4.12

3206

9370

Migraine

8888

48391

1.82

307.65

1.4

1.3

1.30

1.75

u/ml

3.48

2497

13453

Dermatitis

8810

56827

1.76

307.65

1.4

1.3

1.56

1.68

u/ml

0.44

2480

15324

Used for control exclusion in common control thyroid runs

19667

57998

1.98

307.65

1.5

1.2

2.57

1.24

u/ml

23.27

5685

15226

Intestinal infectious diseases

14335

79742

1.53

307.65

1.4

1.3

1.57

1.74

u/ml

0.83

3802

21706

Codeine or tramadol medication

17757

70938

1.51

307.65

1.3

1.49

1.70

u/ml

1.30

4680

19805

General examination and investigation of persons without complaint and reported diagnosis

10114

34319

1.73

307.65

1.3

1.2

1.49

1.77

u/ml

1.49

3499

9875

Headache

11582

59010

1.90

307.65

1.4

1.3

1.27

1.78

u/ml

5.42

3138

16203

ILD medications

18015

72342

1.48

307.65

1.3

1.35

1.82

u/ml

6.37

4754

19928

ILD medications: prednisolone, methylprednisolone, prednisone

16955

70044

1.48

307.65

1.3

1.35

1.79

u/ml

5.35

4470

19360

Other anxiety disorders

8227

45744

1.87

307.65

1.4

1.3

1.34

1.69

u/ml

1.89

1995

13314

Inflammatory bowel disease treatment related agents

18266

74018

1.53

307.65

1.3

1.26

1.81

u/ml

9.33

4915

20260

Insulin, fast-acting or short human

7145

30740

3.17

307.65

1.9

1.2

2.02

1.71

u/ml

1.12

2228

8123

Any mental disorder

17216

63556

1.46

307.65

1.3

1.60

1.79

u/ml

1.04

4408

17824

Coeliac disease

2889

10492

4.90

307.65

2.3

1.3

12.67

1.35

u/ml

69.61

1249

2665

Other functional intestinal disorders

7218

34954

2.39

307.65

1.4

1.3

1.54

1.86

u/ml

1.23

1882

9297

Insulin, intermediate and long-acting

8954

43836

2.48

307.65

1.7

1.2

1.87

1.76

u/ml

0.34

2658

11438

Insulin, fast-acting

7129

30135

3.27

307.65

1.9

1.2

2.02

1.71

u/ml

1.12

2224

7974

Insulin medication

9533

44344

2.18

307.65

1.7

1.2

1.87

1.81

u/ml

0.18

2845

11721

All anxiety disorders

11255

56646

1.87

307.65

1.4

1.3

1.34

1.72

u/ml

2.59

2809

16401

Persons encountering health services for examination and investigation

10333

34333

1.64

307.65

1.3

1.2

1.91

1.77

u/ml

0.42

2738

9876

Irritable bowel syndrome

6106

24226

3.74

307.65

1.4

1.3

0.97

1.75

u/ml

8.17

1609

6836

Benign neoplasm: Colon

6576

36630

2.04

307.65

1.3

1.2

1.63

1.76

u/ml

0.27

1510

9453

Neurological diseases

15202

52952

1.59

307.65

1.3

1.43

1.86

u/ml

4.17

4221

14390

Malaise and fatigue

6664

35272

1.76

307.17

1.4

1.3

1.36

1.77

u/ml

1.90

1663

9284

Osteopathies and chondropathies

7497

46833

1.71

305.94

1.4

1.3

1.35

1.69

u/ml

2.12

2031

12286

Sleep apnoea, including avohilmo

13361

63070

1.49

300.04

1.3

1.24

1.82

u/ml

9.97

3854

17051

Aplastic and other anaemias

5270

30232

1.86

299.50

1.4

1.3

1.76

1.77

u/ml

0.01

1167

7735

Diseases of the eye and adnexa

13995

51015

1.49

297.87

1.4

1.3

1.75

1.73

u/ml

0.06

3928

14215

Nonalcoholic fatty liver disease

1634

6803

3.54

297.72

1.4

1.3

1.20

1.85

u/ml

2.29

345

1860

Atopic dermatitis

9279

54934

1.62

296.30

1.4

1.3

1.62

1.68

u/ml

0.13

2406

15406

Diarrhoea and gastroenteritis of presumed infectious origin

10453

67194

1.55

293.20

1.4

1.3

1.56

1.74

u/ml

0.71

2836

18423

Acute upper respiratory infections

15602

73372

1.43

285.04

1.3

1.49

1.73

u/ml

1.54

4194

19806

Other diseases of upper respiratory tract

16653

65558

1.42

280.82

1.3

1.57

1.77

u/ml

1.07

4201

18041

Other joint disorders

14444

57024

1.46

278.48

1.3

1.39

1.81

u/ml

4.11

4050

15650

Metabolic disorders

12933

58821

1.47

274.37

1.3

1.70

1.74

u/ml

0.15

3279

16269

Other retinal disorders

7585

40743

1.65

274.31

1.5

1.2

1.91

1.69

u/ml

0.62

2114

10401

Other and unspecified polyneuropathies, also in other diseases

2351

11479

2.50

272.65

1.4

1.2

1.44

1.94

u/ml

1.17

533

2938

Diseases of oral cavity, salivary glands and jaws

13420

50598

1.46

266.26

1.3

1.54

1.85

u/ml

2.10

3495

14109

Sleep apnoea

12219

60643

1.48

265.95

1.3

1.23

1.82

u/ml

9.19

3460

16415

Chronic rhinitis, nasopharyngitis and pharyngitis

4721

29081

1.89

263.57

1.3

1.65

1.74

u/ml

0.14

1137

8189

Hypothyroidism, drug reimbursement

2489

8779

2.43

261.16

1.4

1.2

1.72

1.89

u/ml

0.23

684

2617

Abnormalities of heart beat

4859

29732

1.84

260.70

1.3

1.47

1.79

u/ml

0.99

1303

8036

Symptoms and signs involving cognition, perception, emotional state and behaviour

13493

70610

1.44

259.59

1.3

1.60

1.70

u/ml

0.32

3482

19384

Disorders of eyelid, lacrimal system and orbit

11413

65450

1.48

256.49

1.3

1.50

1.68

u/ml

0.74

2982

17653

Cough

5717

35359

1.75

255.74

1.4

1.3

1.71

1.89

u/ml

0.37

1438

9353

Dyspnoea

12018

67824

1.47

255.41

1.3

1.47

1.71

u/ml

1.19

3158

18397

Myalgia

3492

20020

2.09

255.38

1.4

1.3

1.23

1.87

u/ml

3.14

796

5575

ILD medications: immunosuppressive drugs

8908

60387

1.56

253.65

1.3

1.27

1.78

u/ml

4.90

2362

16689

Asthma, unspecified (mode), excluding more controls

7475

39837

1.63

253.24

1.3

1.44

1.78

u/ml

1.56

1941

11151

Personality disorders, excluding more controls

4202

25484

1.94

251.11

1.4

1.3

1.43

1.64

u/ml

0.53

1013

7686

Gingivitis and periodontal diseases

13143

50208

1.45

250.98

1.3

1.57

1.83

u/ml

1.40

3341

14062

Polyneuropathies and other disorders of the peripheral nervous system

2621

13703

2.28

250.32

1.4

1.3

1.48

1.95

u/ml

1.20

596

3507

Nausea and vomiting

3674

20945

2.00

250.19

1.4

1.3

1.45

1.89

u/ml

1.34

959

5401

Triptan medication for migraine, single purchase ok

12444

62814

1.47

249.28

1.3

1.23

1.72

u/ml

5.41

3556

17370

Migraine, single triptan purchase ok & required. ICD-code if available is included

12444

62814

1.47

249.28

1.3

1.23

1.72

u/ml

5.41

3556

17370

Other disorders of urethra and urinary system

9991

53786

1.52

249.00

1.3

1.61

1.64

u/ml

0.10

2548

14625

Asthma (diagnoses ohter than nonallergic)

12570

80429

1.45

248.12

1.3

1.48

1.72

u/ml

1.34

3347

21715

Benzodiazepine use

14187

76503

1.42

247.40

1.3

1.35

1.70

u/ml

2.74

3540

21335

Coxibs

4175

12839

1.93

246.97

1.3

1.35

2.11

u/ml

3.20

1110

3373

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

863

2886

5.44

245.55

1.8

1.2

2.42

1.73

u/ml

0.52

270

886

Rotator cuff syndrome

7599

38523

1.60

243.67

1.3

1.2

1.45

1.82

u/ml

2.00

2268

10400

Asthma, unspecified (mode)

7552

41030

1.60

243.25

1.3

1.43

1.80

u/ml

1.77

1961

11470

Other/unspecified dorsalgia

5169

32798

1.77

242.66

1.3

1.52

1.84

u/ml

0.93

1335

8877

Certain infectious and parasitic diseases

15864

60780

1.40

242.39

1.3

1.78

1.71

u/ml

0.22

4073

17052

Other gastritis (incl. Duodenitis)

2819

15240

2.16

240.66

1.4

1.2

1.87

1.81

u/ml

0.08

716

4069

Other systemic involvement of connective tissue (FG)

3643

21274

1.99

240.45

1.4

1.3

1.56

1.75

u/ml

0.38

1022

5635

Disorders of gallbladder, biliary tract and pancreas

13151

63645

1.43

238.56

1.3

1.37

1.73

u/ml

3.12

3572

17374

Symptoms and signs involving the nervous and musculoskeletal systems

7686

53544

1.59

238.18

1.3

1.37

1.72

u/ml

1.97

2384

14060

Temporomandibular joint disorders

2547

13524

2.28

235.84

1.4

1.2

0.94

1.88

u/ml

6.61

760

3831

Symptoms and signs concerning food and fluid intake

1629

7379

2.91

235.72

1.4

1.3

1.48

1.92

u/ml

0.76

409

1844

Infections, IBD-co-morbidities

2161

7601

2.40

233.37

1.4

1.2

1.89

2.42

u/ml

0.72

517

2057

Dizziness and giddiness

9832

57858

1.50

232.63

1.3

1.61

1.70

u/ml

0.24

2533

15648

Pain and other conditions associated with female genital organs and menstrual cycle

3697

21395

2.02

232.34

1.4

1.3

1.47

1.61

u/ml

0.27

945

5980

Lumbar disc prolapse

8434

47329

1.54

230.64

1.3

1.2

1.57

1.85

u/ml

1.22

2363

12990

Dysphagia

2905

16054

2.09

229.79

1.4

1.2

1.39

1.89

u/ml

1.21

718

4182

Dental caries 1 and operation codes

12109

45992

1.45

228.77

1.3

1.69

1.81

u/ml

0.43

3204

12528

Arthropathies

14727

57289

1.40

227.59

1.3

1.41

1.81

u/ml

3.79

4147

15697

Other disorders of lacrimal gland

4602

29203

1.82

227.51

1.4

1.3

1.37

1.75

u/ml

1.20

1279

7818

Behavioural syndromes associated with physiological disturbances and physical factors

5233

34426

1.77

226.84

1.5

1.3

1.60

1.69

u/ml

0.20

1345

9623

Dental caries 3 and operation codes

12859

49420

1.43

226.02

1.3

1.75

1.78

u/ml

0.08

3408

13463

Special screening examination for infectious and parasitic diseases

4261

19549

1.86

225.39

1.3

1.2

1.47

1.72

u/ml

0.62

750

6030

Pain, not elsewhere classified

3889

23725

1.89

222.88

1.4

1.3

1.21

1.86

u/ml

3.69

1120

6460

Other pulmonary diagnosis

12601

47273

1.43

221.81

1.3

1.51

1.85

u/ml

2.04

3361

13367

Diabetic retinopathy, strict definition

2465

11738

2.35

220.79

1.8

1.4

2.14

1.59

u/ml

1.11

762

3294

Disorders of choroid and retina

9664

51087

1.48

220.50

1.5

1.2

2.02

1.69

u/ml

1.20

2639

13425

Genitourinary diseases

9216

32871

1.51

218.99

1.3

1.68

2.05

u/ml

1.69

2425

9093

Disorders of lacrimal system

5534

36885

1.69

217.55

1.4

1.3

1.44

1.70

u/ml

0.78

1539

9806

Other arthrosis

6434

31039

1.62

217.52

1.3

1.2

1.54

1.84

u/ml

1.06

1666

8398

Symptoms and signs involving the skin and subcutaneous tissue

9316

67923

1.49

216.00

1.3

1.34

1.68

u/ml

2.56

2356

18522

Excluding asthma or asthma-COPD overlap

12556

47273

1.42

215.71

1.3

1.52

1.85

u/ml

1.88

3357

13367

16802

69596

1.35

214.57

1.3

1.54

1.74

u/ml

1.15

4523

18829

Antihypertensive medication - note that there are other indications

11006

44794

1.46

212.82

1.4

1.3

1.54

1.82

u/ml

1.37

3209

12449

Systemic connective tissue disorders

4679

30219

1.76

212.75

1.4

1.3

1.45

1.64

u/ml

0.52

1265

7971

Dental operations

8547

30908

1.52

212.62

1.3

1.2

1.83

1.78

u/ml

0.11

2239

8473

Inflammatory bowel disease

4591

29566

1.78

212.56

1.3

1.27

1.71

u/ml

2.13

1187

8295

Other diseases of anus and rectum

3448

20422

1.90

212.27

1.3

1.2

1.22

1.87

u/ml

3.11

849

5493

Exposure to unspecified factor

13839

83070

1.38

211.94

1.3

1.96

1.68

u/ml

1.23

3053

23225

Temporomandibular joint disorders, including avohilmo

6775

47625

1.61

209.42

1.4

1.3

1.01

1.64

u/ml

10.01

1893

13371

COPD differential diagnosis

12470

47126

1.42

208.69

1.3

1.52

1.85

u/ml

1.99

3343

13296

ILD differential diagnosis

12462

47107

1.42

208.17

1.3

1.52

1.85

u/ml

1.98

3340

13291

Non-selective monoamine reuptake inhibitors

4811

30239

1.71

207.28

1.3

1.2

1.31

1.85

u/ml

2.80

1237

8157

Spinal stenosis

5474

28262

1.65

207.24

1.3

1.2

1.30

2.00

u/ml

4.04

1493

7091

Disturbances of skin sensation

4072

25765

1.85

207.18

1.4

1.3

1.06

1.72

u/ml

6.41

1021

7334

Noninfectious colitis NAS

2067

10797

2.41

206.52

1.5

1.3

1.37

1.83

u/ml

1.06

547

2889

Haemorrhoids and perianal venous thrombosis

3288

19347

1.91

206.23

1.3

1.2

1.34

1.88

u/ml

1.97

858

5160

Fibromyalgia

1546

7367

2.87

204.69

1.4

1.2

1.28

1.50

u/ml

0.28

423

2047

Asthma, hospital admissions , main diagnosis only

11844

81028

1.41

203.42

1.3

1.51

1.72

u/ml

1.14

3278

21904

Other nutritional deficiencies

9168

66227

1.48

203.20

1.3

1.51

1.61

u/ml

0.36

2487

18390

Abnormal findings on examination of blood, without diagnosis

5148

31790

1.67

202.18

1.4

1.3

2.19

1.76

u/ml

1.19

1337

8279

Dental operations, only avohilmo

9015

33168

1.49

201.86

1.3

1.2

1.81

1.75

u/ml

0.11

2366

9123

Acute upper respiratory infections of multiple and unspecified sites

10977

62025

1.43

201.34

1.4

1.3

1.55

1.73

u/ml

0.71

2986

17036

Asthma-related infections

7951

56497

1.51

199.59

1.4

1.3

1.51

1.76

u/ml

0.92

2086

15103

Asthma, hospital admission 2, infections

7951

56497

1.51

199.59

1.4

1.3

1.51

1.76

u/ml

0.92

2086

15103

Chronic sinusitis

5879

40252

1.62

199.20

1.3

1.53

1.66

u/ml

0.31

1453

11482

Dental pulpitis 4, only avohilmo

16510

68114

1.34

199.17

1.3

1.63

1.69

u/ml

0.22

4452

18434

Disorders of conjunctiva

12057

77589

1.40

199.02

1.3

1.65

1.67

u/ml

0.05

3102

21269

Disorders of synovium and tendon

7187

45849

1.54

198.44

1.3

1.68

1.72

u/ml

0.08

2001

12626

Factors influencing health status and contact with health services

4534

14131

1.74

198.00

1.3

1.2

1.94

1.91

u/ml

0.05

1190

4090

6353

43959

1.59

197.97

1.4

1.3

1.49

1.80

u/ml

1.19

1676

11862

Dental pulpitis 1, only avohilmo

16530

68278

1.34

197.71

1.3

1.66

1.69

u/ml

0.10

4464

18470

Chronic lower respiratory diseases

17880

77304

1.32

196.92

1.3

1.55

1.76

u/ml

1.30

4877

21016

Other systemic involvement of connective tissue

3709

23133

1.85

196.79

1.4

1.3

1.55

1.66

u/ml

0.21

1039

6136

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

6744

46423

1.56

195.98

1.3

1.56

1.76

u/ml

0.61

1746

13139

Dental pulpitis 4

16274

66796

1.34

195.93

1.3

1.69

u/ml

0.02

4355

18101

Dental pulpitis 1

16271

66816

1.34

195.44

1.3

1.69

1.70

u/ml

0.02

4356

18105

Diseases of pulp and periapical tissues, including avohilmo

16245

66728

1.34

194.43

1.3

1.69

1.70

u/ml

0.02

4349

18076

Cardiac arrhythmias

9165

44534

1.47

194.35

1.3

1.2

1.51

1.74

u/ml

1.02

2506

12367

Migraine with aura

3993

25620

1.83

194.12

1.3

1.11

1.72

u/ml

3.59

1084

7180

Disorders of lipoprotein metabolism and other lipidaemias

9815

45612

1.45

193.69

1.3

1.2

1.64

1.74

u/ml

0.31

2364

12449

Type 2 diabetes, wide definition

9589

46177

1.45

191.99

1.4

1.2

1.76

u/ml

0.01

2630

12332

Cardiovascular diseases

11024

45505

1.43

188.90

1.3

1.46

1.80

u/ml

2.02

3132

12833

Dental caries 1, only avohilmo

10807

41383

1.42

188.74

1.3

1.76

1.81

u/ml

0.14

2887

11076

Dental caries 1

10623

40578

1.43

187.74

1.3

1.78

1.82

u/ml

0.10

2829

10912

Other disorders of skin and subcutaneous tissue

8415

56596

1.47

187.66

1.3

1.54

1.67

u/ml

0.55

2161

15089

Budesonide

2061

11109

2.29

186.66

1.4

1.3

1.31

1.79

u/ml

1.30

485

3055

Cholelithiasis

10822

57556

1.41

186.11

1.3

1.31

1.68

u/ml

3.06

2943

15641

Excessive, frequent and irregular menstruation

6744

26423

1.59

185.85

1.3

1.25

1.67

u/ml

2.36

1866

7211

Dental caries, including avohilmo

10602

40555

1.42

185.83

1.3

1.78

1.82

u/ml

0.09

2826

10905

Cholecystectomy

8887

58241

1.46

185.71

1.3

1.21

1.68

u/ml

4.43

2431

15668

Complications of surgical and medical care, not elsewhere classified

13093

73230

1.36

184.51

1.3

1.62

1.66

u/ml

0.12

3414

20111

Persons encountering health services in other circumstances

5415

37103

1.63

184.44

1.4

1.3

1.47

1.77

u/ml

0.97

1517

9868

Disorders of other endocrine glands

6071

41903

1.59

183.94

1.4

1.3

1.48

1.75

u/ml

0.95

1624

11095

Dental caries 3, only avohilmo

11619

45203

1.40

182.85

1.3

1.76

1.77

u/ml

0.02

3084

12136

Dental pulpitis 2, only avohilmo

9735

36886

1.44

182.47

1.3

1.83

1.80

u/ml

0.06

2564

9894

Type 2 diabetes

13135

60640

1.37

182.19

1.4

1.2

1.64

1.70

u/ml

0.23

3728

16614

Falls/tendency to fall

17000

68205

1.32

180.31

1.3

1.77

1.67

u/ml

0.41

4361

19297

Weight loss

1417

6809

2.74

180.07

1.4

1.3

1.48

1.62

u/ml

0.16

359

1692

Polyarthropathies

9135

45165

1.45

179.89

1.3

1.45

1.81

u/ml

1.88

2436

12448

Dental pulpitis 2

9565

36253

1.44

179.43

1.3

1.83

1.79

u/ml

0.09

2510

9745

Conjunctivitis

11099

74687

1.40

179.00

1.3

1.62

1.64

u/ml

0.08

2839

20561

Dental caries 3

11424

44456

1.40

178.68

1.3

1.80

1.77

u/ml

0.08

3026

11972

Cholelithiasis, broad definition with cholecystitis

11132

58394

1.39

178.36

1.3

1.31

1.68

u/ml

3.20

3027

15875

Acetic acid derivatives and related substances

3896

12550

1.77

177.28

1.3

1.2

1.70

2.08

u/ml

0.77

1050

3290

Obesity related asthma

4256

28006

1.72

177.08

1.3

1.25

1.80

u/ml

3.22

1197

7634

Dental caries 2 and operation codes

11319

69623

1.39

176.77

1.3

1.44

1.73

u/ml

1.64

2798

19597

Abnormal weight loss

1280

5970

2.85

175.30

1.4

1.3

1.57

1.59

u/ml

0.01

322

1476

Finngen Rheumatological endpoints

14246

64221

1.34

172.70

1.3

1.45

1.72

u/ml

1.82

4017

17809

Other reaction to severe stress, and adjustment disorders

5626

39485

1.59

172.55

1.4

1.3

1.27

1.65

u/ml

1.87

1488

11556

Dental caries 2

11463

70065

1.38

172.22

1.3

1.43

1.73

u/ml

1.87

2839

19727

Vasomotor and allergic rhinitis

5845

40714

1.58

171.02

1.4

1.3

1.53

1.77

u/ml

0.78

1641

11574

Fever of other and unknown origin

7099

47701

1.49

170.32

1.3

1.48

1.81

u/ml

1.50

1895

12781

Complications of procedures, not elsewhere classified

10490

69742

1.39

168.72

1.3

1.55

1.67

u/ml

0.46

2753

19133

Use of hypnotics and sedatives

14404

66132

1.33

168.40

1.3

1.35

1.78

u/ml

4.53

3693

18494

Diseases of the ear and mastoid process

17503

71756

1.30

168.20

1.3

1.77

1.67

u/ml

0.43

4599

19962

Nonorganic sleeping disorders, excluding more controls

2693

16185

1.96

166.75

1.4

1.3

1.61

1.70

u/ml

0.12

659

4697

Other arrhythmias

8544

48869

1.44

166.40

1.3

1.42

1.70

u/ml

1.27

2203

13353

Bronchitis

15091

79379

1.32

166.38

1.3

1.51

1.72

u/ml

1.24

4060

21562

Dentofacial anomalies [including malocclusion]

4152

27324

1.71

166.36

1.4

1.3

1.15

1.82

u/ml

4.85

1183

7739

Oxicams

2892

9580

1.89

166.16

1.3

1.2

1.33

2.12

u/ml

2.76

917

2543

Personality disorders

4202

28163

1.71

165.89

1.4

1.3

1.43

1.62

u/ml

0.45

1013

8143

Other symptoms and signs involving the digestive system and abdomen

2250

12833

2.07

165.27

1.4

1.2

1.17

1.69

u/ml

1.49

632

3411

Menorrhagia

5442

20768

1.62

164.71

1.3

1.26

1.69

u/ml

2.18

1493

5707

Dental caries 2, only avohilmo

11267

69388

1.38

164.55

1.3

1.41

1.72

u/ml

1.99

2794

19541

Pure hypercholesterolaemia

8211

40688

1.45

164.39

1.3

1.2

1.70

1.77

u/ml

0.17

1842

10911

Somatoform disorder

2416

14200

2.04

164.14

1.4

1.3

1.29

1.59

u/ml

0.61

617

3994

Disorders of adult personality and behaviour

4435

30138

1.68

163.51

1.4

1.3

1.54

1.62

u/ml

0.15

1056

8680

Care involving use of rehabilitation procedures

8330

59278

1.44

163.43

1.3

1.65

1.72

u/ml

0.20

1906

16228

Rheumatism, unspecified

1997

11096

2.18

162.94

1.4

1.2

1.41

1.69

u/ml

0.43

575

2952

Chronic diseases of tonsils and adenoids

11846

58648

1.37

162.37

1.3

1.68

1.75

u/ml

0.22

3013

16411

Osteoporosis with pathological fracture (FG)

938

3931

3.22

162.20

1.4

1.2

1.05

1.57

u/ml

1.15

256

945

Fibrosis and cirrhosis of liver

1016

4416

3.07

162.15

1.4

1.2

1.67

1.39

u/ml

0.26

220

1182

Benign neoplasms

14338

63779

1.33

161.81

1.3

1.50

1.78

u/ml

1.70

3914

17953

Migraine without aura

3404

22051

1.82

160.33

1.4

1.3

1.43

1.71

u/ml

0.76

993

6236

Visual disturbances and blindness

6405

46371

1.51

160.12

1.3

1.93

1.71

u/ml

0.50

1505

12310

Cervical disc disorders

4214

28085

1.65

159.27

1.3

1.2

1.35

1.96

u/ml

2.84

1159

7418

Disorders of skin appendages

6776

49685

1.50

159.10

1.4

1.3

1.60

1.68

u/ml

0.20

1857

13683

Hypertension, essential

10383

45424

1.39

159.04

1.3

1.79

1.73

u/ml

0.17

2949

12816

Other external causes of accidental injury

12940

51026

1.34

157.95

1.3

1.79

1.61

u/ml

0.72

3301

14826

KRA_PSY_EATING, excluding more controls

1737

9537

2.42

157.41

1.6

1.3

0.99

1.55

u/ml

2.79

455

2814

Hypertensive diseases (excluding secondary)

7919

34097

1.46

156.57

1.3

1.60

1.75

u/ml

0.50

2348

9668

Benign neoplasm: Colon, unspecified

2601

15581

1.90

156.41

1.3

1.2

1.95

1.88

u/ml

0.07

541

3973

Irregular menses

7739

47239

1.47

155.54

1.3

1.28

1.50

u/ml

1.01

2210

13392

Generalized anxiety disorder

2592

15854

1.98

155.46

1.4

1.3

1.34

1.64

u/ml

0.73

608

4595

Disorders of vitreous body and globe

5560

38463

1.54

154.26

1.3

1.2

1.73

1.68

u/ml

0.08

1459

9851

Disorders of vitreous body

5431

37572

1.55

154.17

1.4

1.2

1.73

1.70

u/ml

0.04

1436

9618

Vocal cord dysfunction

1812

9066

2.15

153.30

1.3

1.2

1.75

2.05

u/ml

0.35

461

2580

Noninflammatory disorders of female genital tract

7416

27507

1.49

152.92

1.4

1.3

1.56

1.71

u/ml

0.41

2072

7460

Acute sinusitis

7496

52227

1.45

152.46

1.4

1.3

1.60

1.67

u/ml

0.17

2092

14605

Visual disturbances

5988

43255

1.52

152.45

1.3

1.89

1.70

u/ml

0.38

1416

11522

Statin medication

9850

42301

1.39

151.78

1.4

1.3

1.61

1.81

u/ml

0.76

2725

12186

Benign neoplasm: Colon, unspecified

2601

15659

1.88

150.63

1.3

1.2

1.95

1.84

u/ml

0.12

541

4089

Inflammatory diseases of female pelvic organs

9460

55234

1.41

150.61

1.3

1.36

1.50

u/ml

0.51

2469

15375

Carpal tunnel syndrome

7560

51047

1.44

149.71

1.3

1.2

1.59

1.70

u/ml

0.31

2190

13811

Other symptoms and signs involving the nervous and musculoskeletal systems

5450

38877

1.54

149.47

1.3

1.29

1.71

u/ml

2.23

1918

10381

Cervicalgia

2609

15881

1.88

149.28

1.3

1.2

1.03

1.90

u/ml

7.12

710

4237

Other enthesopathies

3802

25247

1.68

149.13

1.3

1.2

1.67

1.78

u/ml

0.19

1025

6940

Cervicobrachial syndrome

2899

18145

1.82

149.07

1.3

1.2

1.36

1.93

u/ml

2.11

932

4980

Accidents

12859

51026

1.33

149.01

1.3

1.84

1.61

u/ml

1.00

3309

14826

Endometriosis

5490

23117

1.57

148.13

1.3

1.30

1.65

u/ml

1.68

1460

6392

Hernia of abdominal wall, postoperative

2035

11535

2.01

147.07

1.3

1.2

1.67

1.88

u/ml

0.25

491

3429

Specific personality disorders

3633

24274

1.72

146.07

1.4

1.3

1.46

1.58

u/ml

0.24

879

7020

IBD patients in KELA-register

3275

21292

1.76

146.01

1.3

1.32

1.83

u/ml

1.72

834

6067

Heartburn

1414

7240

2.39

145.99

1.4

1.2

1.17

1.93

u/ml

2.39

353

1972

Concussion

6890

44040

1.46

145.89

1.3

1.82

1.88

u/ml

0.14

1855

11952

Hyperkinetic disorders, excluding more controls

1901

10634

2.19

144.96

1.5

1.4

1.88

1.74

u/ml

0.13

442

3019

Second line medication for Crohn's disease

7494

56533

1.44

144.45

1.3

1.22

1.71

u/ml

4.18

1967

15392

Pain in thoracic spine

2066

11977

2.03

143.98

1.3

1.06

1.83

u/ml

2.64

626

3263

Oter anti-inflammatory and antirheumatic agents, non-steroids

2420

7708

1.90

143.73

1.3

1.2

1.18

2.17

u/ml

3.75

660

2029

Oedema, not elsewhere classified

3581

23469

1.68

143.73

1.4

1.2

1.54

1.85

u/ml

0.86

869

6170

COPD/asthma/ILD related infections

15583

63508

1.29

143.51

1.3

1.56

1.75

u/ml

1.03

4151

17396

COPD/asthma related infections

15583

63508

1.29

143.51

1.3

1.56

1.75

u/ml

1.03

4151

17396

Pruritus

1556

8345

2.31

143.41

1.4

1.3

1.41

1.65

u/ml

0.34

384

2198

Ulcerative colitis

3334

21820

1.73

142.90

1.3

1.36

1.81

u/ml

1.44

844

6164

Complications of medical and surgical care

9049

66450

1.38

141.74

1.3

1.57

1.63

u/ml

0.18

2138

18158

Fenamates

2098

8030

2.00

141.18

1.3

1.2

1.32

1.93

u/ml

1.08

531

2140

Diseases of the respiratory system

9981

38629

1.37

141.08

1.3

1.48

1.85

u/ml

1.94

2664

10774

Syncope and collapse

5209

32724

1.52

139.68

1.3

1.74

1.79

u/ml

0.09

1305

8478

Faecal incontinence

1188

5829

2.55

138.94

1.4

1.2

1.13

1.80

u/ml

1.56

269

1495

Implicit Sepsis

8689

51832

1.39

138.77

1.3

1.80

1.71

u/ml

0.21

2099

13705

Symptoms and signs involving speech and voice

3995

27280

1.63

138.77

1.3

1.42

1.67

u/ml

0.69

965

7330

Other specified/unspecified arthritis

3411

22497

1.69

138.72

1.3

1.39

1.88

u/ml

1.65

939

6070

Voice disturbances

3344

22106

1.72

137.79

1.3

1.44

1.68

u/ml

0.54

810

5979

Haemorrhage from respiratory passages

3566

21847

1.65

136.72

1.3

1.73

1.99

u/ml

0.46

887

5601

Urticaria and erythema

5139

36998

1.54

136.63

1.4

1.3

1.69

1.74

u/ml

0.10

1379

10180

Ovarian cyst

5845

24514

1.52

136.62

1.3

1.36

1.63

u/ml

0.88

1604

6764

Polyuria

2454

15012

1.85

136.29

1.3

1.2

1.85

1.83

u/ml

0.01

527

3937

Obesity and other hyperalimentation

8385

64169

1.39

135.58

1.3

1.48

1.62

u/ml

0.54

2256

17868

Obesity

8347

63929

1.39

134.92

1.3

1.48

1.62

u/ml

0.52

2246

17802

Intestinal malabsorption

759

3209

3.43

133.84

1.6

1.2

3.16

1.33

u/ml

1.91

235

834

Atopic dermatitis, strict definition with reimbursement

4860

33801

1.56

133.51

1.4

1.3

2.07

1.71

u/ml

0.87

1274

9431

Subjective visual disturbances

3154

20764

1.73

133.24

1.3

1.62

1.76

u/ml

0.25

706

5567

Inflammatory bowel disease, strict (require KELA)

3275

21747

1.71

132.91

1.3

1.32

1.76

u/ml

1.38

834

6134

Reimbursement for rheumatic diseases

7414

56347

1.41

132.37

1.3

1.23

1.65

u/ml

3.19

1998

15065

Diseases of pulp and periapical tissues

4200

29105

1.58

131.67

1.3

1.70

1.79

u/ml

0.16

999

8198

Symptoms and signs involving the urinary system

9032

54234

1.37

131.37

1.3

1.54

1.75

u/ml

0.96

2144

14451

5-aminosalicylic acid

2962

19249

1.75

131.02

1.3

1.30

1.86

u/ml

1.70

730

5467

Fall on same level

16639

77021

1.26

130.85

1.3

1.82

1.70

u/ml

0.47

4061

21573

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1109

3782

2.45

130.84

1.3

1.2

1.06

3.02

u/ml

5.87

269

931

Sleep disorders

3031

19922

1.75

130.34

1.4

1.3

1.83

1.69

u/ml

0.18

766

5554

Triptan medication for migraine, min. 3 purchases

8711

53749

1.39

129.52

1.3

1.37

1.56

u/ml

0.84

2533

15238

Panic disorder

2418

15230

1.88

127.91

1.4

1.3

1.91

1.66

u/ml

0.31

590

4422

Propionic acid derivatives

4273

14600

1.59

127.90

1.3

1.54

2.26

u/ml

2.15

1104

3695

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1525

8302

2.14

127.82

1.4

1.2

2.51

2.06

u/ml

0.44

296

2201

Other arthritis (FG)

3894

26865

1.60

127.06

1.3

1.38

1.83

u/ml

1.66

1080

7239

Migraine with aura and triptan purchases

2518

16125

1.87

127.02

1.4

1.3

1.05

1.62

u/ml

2.44

697

4578

Paracetamol of NSAID medication

2947

9295

1.74

126.63

1.3

1.4

1.71

2.39

u/ml

1.37

771

2311

Polycystic ovarian syndrome, consortium definition

11146

54085

1.34

125.01

1.3

1.33

1.53

u/ml

1.01

3043

14910

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4010

28003

1.59

124.69

1.4

1.3

1.19

1.66

u/ml

2.13

1003

8393

Diabetic retinopathy, excluding more controls

3242

12069

1.73

124.16

1.7

1.3

1.83

1.56

u/ml

0.55

948

3189

Urticaria

4281

30446

1.58

123.38

1.4

1.3

1.57

1.74

u/ml

0.37

1137

8356

Asthma/COPD (KELA code 203)

13334

76912

1.28

123.31

1.3

1.55

1.76

u/ml

1.13

3658

20909

Other diseases of intestine

1310

6852

2.23

122.98

1.3

1.2

2.59

2.23

u/ml

0.26

280

1841

External causes of morbidity and mortality

10622

42195

1.33

122.42

1.3

1.62

u/ml

0.00

2776

12320

L04AX Other immunosuppressants

7145

54803

1.41

122.22

1.3

1.22

1.72

u/ml

4.28

1868

14906

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

7886

60381

1.39

121.98

1.3

1.55

1.59

u/ml

0.09

2012

16827

Fissure and fistula of anal and rectal regions

2801

18129

1.71

121.93

1.3

1.2

1.25

1.85

u/ml

2.24

716

5089

Other disorders of fluid, electrolyte and acid-base balance

3136

20021

1.66

121.67

1.4

1.3

1.96

1.81

u/ml

0.18

782

5136

Any operation in hilmo

849

1753

2.83

121.60

1.3

1.1

1.32

1.73

u/ml

0.54

224

550

Persons encountering health services for specific procedures and health care

14963

76691

1.27

121.37

1.3

1.74

1.71

u/ml

0.09

3615

21378

Other symptoms and signs involving cognitive functions and awareness

4628

30944

1.51

121.22

1.3

1.2

1.63

1.77

u/ml

0.27

1095

8014

Sicca syndrome [Sjögren]

1261

6727

2.39

120.96

1.4

1.3

2.35

1.72

u/ml

0.70

356

1787

Allergic conjunctivitis

8223

63463

1.38

120.82

1.3

1.53

1.60

u/ml

0.20

2109

17648

Hypertension

10548

47601

1.32

118.15

1.3

1.76

u/ml

0.01

3042

13330

Benign neoplasm: Sigmoid colon

1919

11467

1.91

117.48

1.3

1.2

1.52

1.91

u/ml

0.72

451

2939

Glucagon-like peptide-1 (GLP-1) analogues

5601

33981

1.45

117.41

1.3

1.2

1.66

1.82

u/ml

0.38

1380

8707

Papulosquamous disorders

4651

33605

1.51

117.32

1.3

1.69

1.65

u/ml

0.06

1257

9027

Hypertensive diseases

10548

47670

1.32

116.92

1.3

1.76

u/ml

0.01

3042

13348

Soft tissue disorders related to use, overuse and pressure

3004

19941

1.66

116.91

1.3

1.2

1.38

1.86

u/ml

1.97

790

5321

Migraine without aura and triptan purchases

2651

17487

1.79

116.81

1.4

1.3

1.23

1.67

u/ml

1.43

778

5029

Benign neoplasms

11822

54223

1.30

116.35

1.3

1.53

1.78

u/ml

1.16

3280

15616

Thyroiditis, ILD-related definition

1736

10305

2.05

116.25

1.5

1.3

1.43

1.62

u/ml

0.32

476

2848

Other heart diseases, wide

12925

65734

1.28

115.62

1.3

1.63

1.73

u/ml

0.37

3510

18191

Injuries to the ankle and foot

9731

71073

1.33

115.48

1.3

1.79

1.69

u/ml

0.24

2450

19947

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3517

22398

1.66

115.34

1.5

1.4

1.68

1.84

u/ml

0.27

827

6116

Condition for Implicit Sepsis (Organ dysfunction codes)

10486

61180

1.31

115.14

1.3

1.72

1.71

u/ml

0.02

2593

16542

Obesity due to excess calories

6123

46444

1.43

115.06

1.3

1.51

1.66

u/ml

0.41

1695

12961

Anti-inflammatory and antirheumatic products, non-steroids

4198

14602

1.55

114.65

1.3

1.62

2.26

u/ml

1.81

1078

3696

Benign neoplasm: Sigmoid colon

1919

11551

1.90

114.41

1.3

1.2

1.52

1.90

u/ml

0.71

451

3038

Bipolar affective disorders

2728

18019

1.73

113.96

1.4

1.3

1.72

1.61

u/ml

0.14

688

5319

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7204

55489

1.38

113.80

1.3

1.67

1.65

u/ml

0.05

1679

15109

Provisional assignment of new diseases of uncertain etiology

5980

45277

1.43

113.35

1.3

1.47

1.64

u/ml

0.55

1746

12454

Persistent mood disorders

2551

16564

1.74

113.13

1.4

1.3

1.18

1.65

u/ml

1.90

601

4621

Codes for special purposes

5981

45327

1.43

112.61

1.3

1.47

1.65

u/ml

0.58

1746

12473

Nonorganic sleeping disorders

2693

17853

1.74

112.16

1.4

1.3

1.61

1.67

u/ml

0.08

659

5012

Cardiovascular diseases (excluding rheumatic etc)

10528

48969

1.32

112.11

1.3

1.50

1.75

u/ml

1.18

3033

13773

Allergic asthma (mode), excluding more controls

3700

25537

1.57

110.43

1.4

1.3

1.53

1.88

u/ml

0.93

1020

7309

Intracranial trauma

7846

45720

1.36

110.35

1.3

1.81

1.86

u/ml

0.11

2096

12437

Polyarthrosis

2197

13209

1.79

109.55

1.3

1.2

1.18

2.01

u/ml

4.78

638

3394

Postmenopausal atrophic vaginitis

3137

12679

1.66

109.21

1.3

1.2

1.46

1.74

u/ml

0.55

894

3346

Exposure to other specified factors

9799

74153

1.31

108.87

1.3

1.83

1.74

u/ml

0.21

2392

20513

Allergic asthma (mode)

3700

25648

1.57

107.97

1.4

1.3

1.53

1.88

u/ml

0.92

1020

7333

Presence of other functional implants

5881

31260

1.41

106.70

1.4

1.2

1.62

1.76

u/ml

0.34

1725

7688

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6839

48926

1.37

106.63

1.3

1.60

1.70

u/ml

0.32

1673

12794

Disorders of lens

7372

35948

1.37

106.60

1.3

1.2

2.06

1.76

u/ml

0.79

1902

9498

Allergic rhinitis

4763

35015

1.49

106.39

1.4

1.3

1.52

1.78

u/ml

0.75

1313

9695

Deforming dorsopathies

3497

24470

1.57

106.07

1.3

1.32

1.89

u/ml

2.14

962

6451

Hyperlipidaemia, other/unspecified

3726

24752

1.53

105.93

1.3

1.2

1.33

1.88

u/ml

2.91

1035

6312

Diabetic retinopathy

3704

16417

1.59

105.80

1.6

1.3

1.95

1.57

u/ml

0.88

1049

4465

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6682

51639

1.38

105.80

1.3

1.73

1.63

u/ml

0.22

1552

14024

Eating disorder

1741

10800

2.06

105.65

1.6

1.4

0.99

1.53

u/ml

2.61

455

3006

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4218

30647

1.52

105.33

1.4

1.3

1.54

1.76

u/ml

0.72

1081

8267

Arthrosis

8768

38029

1.33

104.88

1.3

1.2

1.66

1.79

u/ml

0.39

2507

10534

Eating disorders

1937

12272

1.94

104.83

1.6

1.3

1.05

1.50

u/ml

2.07

523

3408

Benign neoplasm: Ascending colon

1386

7841

2.07

104.18

1.3

1.2

1.63

1.78

u/ml

0.16

308

1996

Cirrhosis of liver, NAS

628

2679

3.10

103.93

1.4

1.2

2.36

1.55

u/ml

0.52

125

709

Dental caries

3096

21008

1.61

103.71

1.4

1.3

1.72

2.03

u/ml

0.65

704

5794

Phobic anxiety disorders

2131

13688

1.83

103.62

1.4

1.3

1.46

1.75

u/ml

0.53

517

3952

Benign neoplasm of other and ill-defined parts of digestive system

2002

12546

1.83

103.42

1.3

1.2

1.44

1.76

u/ml

0.46

550

3245

Benign neoplasm: Ascending colon

1386

7864

2.06

103.20

1.3

1.2

1.63

1.93

u/ml

0.37

308

2038

Obesity, other/unspecified

4439

32653

1.49

102.68

1.3

1.57

1.70

u/ml

0.27

1126

9381

Other disorders of glucose regulation and pancreatic internal secretion

1125

6034

2.28

102.67

1.7

1.3

1.65

1.62

u/ml

0.03

320

1541

Chronic pancreatitis

1311

7301

2.08

102.32

1.4

1.2

1.86

2.10

u/ml

0.21

323

1918

Postmenopausal osteoporosis with pathological fracture

757

3548

2.79

101.92

1.4

1.3

1.12

1.57

u/ml

0.72

195

838

Asthma and allergy

2196

14035

1.79

101.73

1.4

1.3

1.34

1.85

u/ml

1.34

567

3955

Other extrapyramidal and movement disorders in other diseases

2500

16527

1.70

101.54

1.3

1.45

1.77

u/ml

0.60

637

4361

Thyrotoxicosis, other and/or unspecified

2543

16947

1.70

101.17

1.4

1.3

1.82

1.66

u/ml

0.25

663

4542

Asthma and allergy, excluding more controls

2196

14102

1.78

99.68

1.4

1.3

1.34

1.83

u/ml

1.25

567

3969

Excessive attrition of teeth

5785

23838

1.43

99.66

1.3

1.47

1.82

u/ml

1.33

1529

6760

Other diseases of the digestive system

3075

21127

1.57

98.70

1.3

1.2

1.76

1.30

u/ml

1.05

742

5287

Benign neoplasm of other and ill-defined parts of digestive system

2002

12698

1.80

98.51

1.3

1.2

1.44

1.76

u/ml

0.46

550

3383

Non-invasive ventilation

2520

15640

1.66

98.38

1.3

1.2

4.57

1.89

u/ml

2.36

195

4386

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2728

18477

1.64

98.11

1.3

1.25

1.78

u/ml

1.93

802

5086

Dentinal caries

2707

18198

1.63

97.49

1.4

1.3

1.74

1.98

u/ml

0.42

625

4974

Injuries to the abdomen, lower back, lumbar spine and pelvis

4508

33106

1.46

97.47

1.3

1.83

1.69

u/ml

0.27

1146

8863

Injuries to the thorax

4756

35372

1.44

97.42

1.3

1.93

1.75

u/ml

0.30

1206

9425

Impingement syndrome of shoulder

2668

17971

1.63

96.49

1.3

1.2

1.56

1.89

u/ml

0.75

666

4770

Injury, poisoning and certain other consequences of external causes

8657

34535

1.32

96.44

1.3

1.70

1.64

u/ml

0.16

2347

9794

Atopic dermatitis, strict definition

4657

34332

1.47

96.34

1.4

1.3

2.02

1.68

u/ml

0.81

1216

9563

Artrosis, including avohilmo

10556

47168

1.28

96.09

1.3

1.53

1.75

u/ml

1.14

3061

13059

Emotionally unstable personality disorder

2011

13039

1.84

96.08

1.4

1.3

1.49

1.59

u/ml

0.13

446

3838

Other cataract

4427

25089

1.46

96.07

1.3

1.2

2.19

1.84

u/ml

0.63

1180

6405

Disturbance of activity and attention

1830

11544

1.92

95.70

1.5

1.4

1.95

1.83

u/ml

0.11

424

3080

Adhesive capsulitis of shoulder

1896

11887

1.79

95.63

1.4

1.2

1.55

1.96

u/ml

0.81

587

3192

Other (not insulin) diabetes medications

11722

58339

1.26

95.41

1.3

1.2

1.57

1.72

u/ml

0.58

3179

15942

Undetermined asthma, excluding more controls

1635

9925

1.89

95.15

1.4

1.3

1.59

2.01

u/ml

0.55

409

2691

Abnormal serum enzyme levels

2650

17605

1.61

94.00

1.3

1.2

1.75

1.90

u/ml

0.24

664

4497

Undetermined asthma

1635

9979

1.88

93.24

1.4

1.3

1.59

2.00

u/ml

0.53

409

2717

Viral Sepsis

2128

13818

1.72

92.68

1.4

1.3

2.13

1.87

u/ml

0.25

522

3522

Crohn disease

1781

11209

1.85

92.63

1.4

1.3

1.02

1.81

u/ml

4.70

457

3099

Infections of the skin and subcutaneous tissue

7196

56902

1.34

92.49

1.4

1.3

1.85

1.76

u/ml

0.18

1838

15701

Insomnia

2176

14368

1.74

92.30

1.4

1.3

1.94

1.70

u/ml

0.27

550

4036

Endometriosis of pelvic peritoneum

2355

15597

1.70

91.90

1.3

1.31

1.72

u/ml

1.14

663

4442

Other diseases of lip and oral mucosa

1815

11389

1.80

91.79

1.3

1.2

1.56

1.96

u/ml

0.72

426

3128

Implicit viral Sepsis

2120

13784

1.72

91.78

1.4

1.3

2.13

1.88

u/ml

0.25

519

3515

Other and unspecified disorders of vitreous body

4246

31272

1.46

91.71

1.3

1.2

1.71

1.66

u/ml

0.08

1096

7906

Benign neoplasm: Rectum

1785

11183

1.80

90.73

1.3

1.2

2.05

1.91

u/ml

0.11

383

2861

Extrapyramidal and movement disorders

3767

27356

1.49

90.65

1.3

1.66

1.74

u/ml

0.12

953

7103

Gonarthrosis

7342

33136

1.33

90.09

1.3

1.2

1.75

1.85

u/ml

0.21

2036

9049

Senile cataract

6416

30875

1.36

89.50

1.3

1.2

2.07

1.79

u/ml

0.61

1578

8007

Benign neoplasm: Rectum

1785

11223

1.79

89.44

1.3

1.2

2.05

1.89

u/ml

0.13

383

2960

Hyperkinetic disorders

1920

12443

1.85

89.20

1.5

1.4

2.03

1.85

u/ml

0.15

445

3283

Tonsillectomy and adenotomy

8881

50440

1.31

89.12

1.3

1.55

1.69

u/ml

0.42

2337

14632

Other eating disorders

1043

5935

2.41

88.70

1.6

1.4

1.10

1.68

u/ml

1.60

272

1595

Hernia

11659

65890

1.25

88.42

1.3

1.78

1.73

u/ml

0.15

2973

18154

Other disorders of teeth and supporting structures

2328

15557

1.65

87.95

1.3

1.2

1.49

1.86

u/ml

0.76

622

4316

Diseases of male genital organs

5244

19903

1.40

87.30

1.3

2.15

2.16

u/ml

0.02

1401

5436

Internal derangement of knee

4482

33525

1.43

87.25

1.3

1.58

1.78

u/ml

0.40

1195

9319

Post-traumatic stress disorder

1392

8471

2.02

87.22

1.4

1.3

1.36

1.46

u/ml

0.13

341

2490

Paralytic ileus and intestinal obstruction

2359

15725

1.62

87.04

1.3

1.2

1.92

1.96

u/ml

0.04

622

4204

Substance abuse, excluding more controls

6422

44114

1.34

86.82

1.3

1.72

1.80

u/ml

0.17

1557

12674

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2359

16020

1.66

85.72

1.3

1.49

1.77

u/ml

0.50

600

4516

Benign neoplasm: Stomach

1120

6333

2.10

85.69

1.3

1.2

1.66

1.46

u/ml

0.20

291

1644

Mouth breathing

4566

34504

1.42

85.36

1.3

1.59

1.85

u/ml

0.72

1237

9180

Cervicocranial syndrome

1348

8023

1.95

85.34

1.3

1.2

1.08

1.81

u/ml

1.78

422

2179

Pollen allergy

3000

21289

1.59

85.30

1.4

1.58

1.85

u/ml

0.55

736

5817

Benign neoplasm: Stomach

1120

6353

2.09

84.82

1.3

1.2

1.66

1.78

u/ml

0.11

291

1661

Trigger finger

1667

10467

1.81

84.69

1.4

1.2

1.65

1.87

u/ml

0.27

459

2826

Benign neoplasm: Rectum, anus and anal canal

1970

12818

1.71

84.56

1.3

1.2

1.96

1.84

u/ml

0.10

420

3289

GI-bleeding

2995

21074

1.53

84.34

1.3

1.2

1.61

1.32

u/ml

0.66

733

5258

Female infertility

4645

21697

1.44

84.34

1.3

1.43

1.59

u/ml

0.41

1489

6106

1786

11495

1.79

84.17

1.4

1.3

0.91

1.71

u/ml

5.09

435

3163

Fracture of lumbar spine and pelvis

2164

14346

1.66

84.10

1.3

1.2

1.67

1.77

u/ml

0.12

510

3642

Trochanteric bursitis

1604

10016

1.83

84.08

1.3

1.2

1.37

1.77

u/ml

0.90

443

2651

Continuous positive airway pressure

1952

10825

1.70

83.75

1.3

1.2

2.32

2.28

u/ml

0.03

290

2891

Thyrotoxicosis

3110

22348

1.54

83.29

1.4

1.3

1.70

1.63

u/ml

0.12

813

6108

Other and unspecified effects of external causes

3691

27304

1.49

83.27

1.4

1.3

1.58

1.69

u/ml

0.17

985

7599

Chronic laryngitis and laryngotracheitis

1601

10005

1.82

83.01

1.3

1.2

1.01

1.83

u/ml

4.63

280

2765

Mycoses

3004

21406

1.54

82.95

1.3

2.18

1.75

u/ml

0.66

761

5761

Deviated nasal septum

3467

25162

1.48

82.44

1.3

1.79

1.85

u/ml

0.09

897

7037

Ulcerative colitis (strict definition, require KELA)

2196

14836

1.67

82.13

1.3

1.51

1.77

u/ml

0.40

554

4178

Benign neoplasm: Rectum, anus and anal canal

1970

12911

1.69

81.92

1.3

1.2

1.96

1.87

u/ml

0.08

420

3404

Ulcerative colitis (strict definition, all Crohn cases excluded)

1887

12368

1.74

81.55

1.3

1.63

1.77

u/ml

0.18

487

3438

Monoamine oxidase A inhibitors

1396

8460

1.88

81.49

1.3

1.2

1.29

1.79

u/ml

1.03

357

2282

Benign neoplasm: Caecum

1060

5975

2.08

81.00

1.3

1.2

1.50

1.83

u/ml

0.40

241

1494

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2121

14294

1.68

80.41

1.3

1.54

1.74

u/ml

0.29

539

4018

Gastroduodenal ulcer

2265

15166

1.60

80.16

1.3

1.2

1.90

1.89

u/ml

0.02

569

3957

Gonarthrosis [arthrosis of knee](FG)

8555

40913

1.28

80.04

1.3

1.2

1.74

1.79

u/ml

0.11

2333

11164

Other bacterial intestinal infections

1919

12593

1.69

79.19

1.4

1.2

1.75

1.80

u/ml

0.04

442

3299

Other heart diseases

6730

35437

1.33

79.14

1.3

1.66

1.83

u/ml

0.50

1862

9846

Injuries to the knee and lower leg

16161

79883

1.20

78.81

1.3

1.86

1.66

u/ml

0.90

4212

21853

Unspecified/other endometriosis

1450

9088

1.90

78.80

1.4

1.3

1.43

1.74

u/ml

0.43

381

2641

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2522

17828

1.62

78.29

1.4

1.3

1.35

1.51

u/ml

0.27

655

5109

Enthesopathies of lower limb, excluding foot

2570

17966

1.57

78.00

1.3

1.26

1.94

u/ml

3.07

661

4924

Hypo-osmolality and hyponatraemia

1669

10591

1.74

77.97

1.3

1.2

2.05

1.81

u/ml

0.22

430

2684

Female infertility, cervigal, vaginal, other or unspecified origin

4137

20877

1.45

77.90

1.3

1.35

1.59

u/ml

0.68

1296

5895

Benign neoplasm: Caecum

1060

6052

2.05

77.70

1.3

1.2

1.50

1.90

u/ml

0.51

241

1547

Fracture of rib(s), sternum and thoracic spine

2854

20283

1.52

77.16

1.3

1.2

1.90

1.77

u/ml

0.17

708

5325

Other and unspecified urticaria

2631

18699

1.58

76.47

1.4

1.3

1.50

1.67

u/ml

0.27

663

5114

Disorders of vestibular function (Vertigo)

4970

38331

1.37

76.25

1.3

1.79

1.64

u/ml

0.27

1234

10034

Inflammatory diseases of prostate (prostatitis)

1100

6281

1.94

75.95

1.3

1.2

2.87

2.02

u/ml

0.65

247

1694

Tinnitus

2590

18252

1.56

75.87

1.3

1.48

1.86

u/ml

0.76

595

4900

Female genital prolapse

3722

15862

1.47

75.82

1.3

1.25

1.78

u/ml

2.27

986

4306

Hypoglycaemia, other or unspecified

880

4817

2.22

75.72

1.7

1.3

1.19

1.64

u/ml

0.79

250

1229

Exclusions for E4_PCOS_BROAD

2191

15075

1.64

75.30

1.5

1.4

1.25

1.89

u/ml

3.07

637

3966

Lichen simplex chronicus and prurigo

785

4141

2.32

75.30

1.4

1.2

2.14

1.50

u/ml

0.65

191

1089

Chronic periapical parodontitis

2191

14925

1.61

75.22

1.3

1.2

2.00

1.85

u/ml

0.15

510

4162

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

12337

71276

1.22

75.17

1.3

1.64

1.70

u/ml

0.21

3382

19224

Diseases of salivary glands

2212

15143

1.61

75.00

1.3

1.47

1.91

u/ml

0.68

586

4198

Bleeding

9106

54793

1.26

74.77

1.3

1.76

1.74

u/ml

0.04

2340

14392

Other disorders of eyelid

4350

32055

1.39

74.65

1.3

1.2

1.52

1.69

u/ml

0.43

1052

8157

Restless leg syndrome

1417

8893

1.84

74.22

1.4

1.3

1.47

1.59

u/ml

0.15

386

2350

Recurring oral aphthae, including avohilmo

1720

11329

1.74

73.81

1.4

1.3

1.50

1.80

u/ml

0.48

432

2900

Covid-19 confirmed case

3294

24319

1.47

73.41

1.4

1.3

1.22

1.73

u/ml

2.36

968

6605

Mucosal proctocolitis

1639

10660

1.75

73.28

1.3

1.11

1.74

u/ml

1.65

392

2972

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4207

32058

1.42

73.20

1.5

1.3

1.71

1.65

u/ml

0.10

1058

9039

Transport accidents

6041

42746

1.32

72.79

1.3

1.98

1.62

u/ml

0.84

1572

12484

Obsessive-compulsive disorder

1076

6414

2.07

72.43

1.5

1.3

1.34

1.55

u/ml

0.22

263

1793

Fibroblastic disorders

2240

15367

1.57

72.40

1.3

1.2

2.07

1.94

u/ml

0.13

525

4027

Vitreous haemorrhage

1076

6290

1.98

72.20

1.6

1.2

2.00

1.62

u/ml

0.37

310

1620

Other disorders of ear

10942

61490

1.23

72.19

1.3

1.52

1.76

u/ml

1.29

2808

16514

Thyrotoxicosis with diffuse goitre

1815

12127

1.70

72.19

1.4

1.3

1.75

1.51

u/ml

0.34

487

3316

Non-allergic asthma (mode), excluding more controls

2366

16353

1.57

72.14

1.3

1.19

2.07

u/ml

4.84

658

4340

Viral and other specified intestinal infections

3185

23004

1.49

71.98

1.5

1.3

1.85

1.82

u/ml

0.03

908

6072

Use of pramipexole

2250

15605

1.59

71.54

1.3

1.2

1.69

1.79

u/ml

0.14

616

4046

Diseases of tongue

781

4177

2.26

71.53

1.4

1.2

1.05

1.85

u/ml

1.63

210

1108

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

5350

27582

1.38

71.45

1.3

1.10

1.50

u/ml

3.30

1568

8208

Other menopausal disorders

3427

14560

1.48

71.30

1.3

1.01

1.73

u/ml

4.53

1001

3974

Disorders of sclera, cornea, iris and ciliary body

6401

51706

1.31

70.86

1.3

1.77

1.67

u/ml

0.23

1853

14097

Other obstetric conditions, not elsewhere classified

5442

28157

1.37

70.83

1.3

1.10

1.54

u/ml

4.04

1598

8388

Neoplasms

11744

53413

1.23

70.82

1.3

1.40

1.82

u/ml

3.54

3187

15372

Psoriasis

3175

23428

1.47

70.44

1.3

1.83

1.69

u/ml

0.20

837

6368

3538

24797

1.43

70.39

1.3

1.2

1.97

1.82

u/ml

0.20

850

6014

Diseases of inner ear

5737

44811

1.32

69.98

1.3

1.77

1.65

u/ml

0.25

1415

11808

Rheumatoid arthritis

3558

24175

1.43

69.95

1.3

1.2

1.10

1.82

u/ml

5.15

932

6476

TMD related operations

2151

14983

1.62

69.81

1.3

0.95

1.69

u/ml

4.74

637

4234

Iron deficiency

432

1965

3.57

69.79

1.6

1.3

1.14

1.66

u/ml

0.64

140

523

Radiculopathy

1667

10884

1.68

69.42

1.3

1.2

1.68

1.97

u/ml

0.33

466

2823

Non-allergic asthma (mode)

2366

16475

1.55

69.39

1.3

1.19

2.07

u/ml

4.93

658

4391

Intracranial injury

6842

53830

1.29

69.21

1.3

1.70

1.80

u/ml

0.25

1782

14390

Lichen ruber planus, wide definition including periferal and oral lichen planus

2293

16109

1.57

69.09

1.3

1.62

1.78

u/ml

0.28

637

4222

Other neurological diseases

7621

50272

1.27

69.01

1.3

1.52

1.71

u/ml

0.66

2024

13102

Asthma-related pneumonia or sepsis

3729

28136

1.41

68.93

1.3

1.71

1.91

u/ml

0.32

971

7293

Asthma, hospital admissions 3, pneumonia

3729

28136

1.41

68.93

1.3

1.71

1.91

u/ml

0.32

971

7293

Asthma-related pneumonia

3719

28051

1.41

68.92

1.3

1.71

1.91

u/ml

0.33

971

7268

Fall on same level involving ice and snow

6713

54681

1.29

68.92

1.3

1.90

1.63

u/ml

0.73

1714

14694

Adverse effects, not elsewhere classified

2606

18854

1.54

68.46

1.4

1.3

1.45

1.69

u/ml

0.42

673

5177

Skin changes due to chronic exposure to nonionizing radiation

3261

22795

1.44

68.46

1.3

1.2

1.99

1.81

u/ml

0.23

784

5475

Atrial fibrillation and flutter with reimbursement

2789

12763

1.50

68.15

1.3

1.2

2.01

1.99

u/ml

0.02

737

3284

Abnormal results of function studies

1064

6353

1.98

68.14

1.4

1.3

1.34

1.72

u/ml

0.65

285

1687

Other maternal disorders predominantly related to pregnancy

8557

44910

1.27

67.99

1.3

1.46

1.50

u/ml

0.13

2610

12392

Allergic contact dermatitis

1797

12142

1.68

67.98

1.4

1.3

2.00

1.48

u/ml

0.85

435

3402

Diseases of middle ear and mastoid

8015

54484

1.27

67.79

1.4

1.3

2.07

1.62

u/ml

1.55

2067

15256

Other disorders of bladder

1151

6931

1.87

67.55

1.3

1.2

2.14

1.81

u/ml

0.27

276

1807

Special screening examination for other diseases and disorders

1078

6410

1.93

67.54

1.4

1.2

2.51

1.79

u/ml

0.53

238

1730

Implicit bacterial Sepsis

3558

24447

1.41

67.39

1.3

1.2

1.87

1.89

u/ml

0.03

799

6175

Erosion of teeth, including avohilmo

2714

19113

1.52

67.31

1.4

1.3

1.57

1.79

u/ml

0.38

654

5541

Other sleep disorders

1261

7830

1.83

67.14

1.4

1.3

1.47

2.31

u/ml

1.52

430

2099

Other general symptoms and signs

762

4132

2.29

67.10

1.5

1.4

2.27

1.95

u/ml

0.19

228

1042

Adenomyosis (Endometriosis of uterus)

1641

10879

1.71

67.00

1.3

1.26

1.81

u/ml

1.60

388

2920

Crohn's disease of small intestine

947

5537

2.07

66.55

1.4

1.3

0.90

1.67

u/ml

2.80

263

1532

Renal failure

3788

26215

1.39

66.54

1.3

1.2

1.92

1.87

u/ml

0.06

882

6574

Parodontitis and operation codes

9866

64751

1.23

66.34

1.3

1.69

1.72

u/ml

0.07

2381

17932

Bullous disorders

662

3435

2.35

66.30

1.7

1.2

4.50

1.62

u/ml

3.04

208

873

Coxarthrosis

4942

26164

1.34

66.17

1.3

1.2

1.74

1.84

u/ml

0.18

1230

6915

Heart failure, not strict

7804

44350

1.27

65.89

1.3

1.87

1.73

u/ml

0.36

1957

11493

Bacterial intestinal infections, IBD co-morbidities

1907

13000

1.61

65.82

1.4

1.3

1.65

1.82

u/ml

0.19

431

3406

Actinic keratosis

3126

21920

1.44

65.75

1.3

1.2

1.92

1.77

u/ml

0.19

758

5248

Spondylolisthesis/Spondylolysis

1956

13424

1.60

65.29

1.3

1.2

1.05

1.96

u/ml

3.72

551

3547

Other enthesopathy of foot (+metatarsalgia)

1246

7804

1.83

65.25

1.3

1.2

1.54

1.70

u/ml

0.17

293

2077

Ulcer of lower limb, not elsewhere classified

1255

7800

1.79

64.79

1.4

1.2

1.85

1.91

u/ml

0.05

283

1995

Mixed and other personality disorders

1123

6926

1.92

64.60

1.4

1.3

1.61

1.62

u/ml

0.01

252

2022

Amenorrhoea

1163

7290

1.93

64.54

1.5

1.3

2.08

1.76

u/ml

0.26

340

2051

Poisoning by drugs, medicaments and biological substances

3192

24011

1.45

64.47

1.4

1.3

1.19

1.66

u/ml

1.87

760

6811

Atrial fibrillation and flutter

3600

17668

1.41

64.19

1.3

1.2

1.82

1.88

u/ml

0.09

968

4796

Benign neoplasm: Transverse colon

983

5790

1.95

64.01

1.3

1.2

1.03

1.83

u/ml

3.60

223

1490

STROKE

6283

35269

1.29

63.74

1.3

1.2

1.35

1.80

u/ml

2.87

1629

9203

Persons with potential health hazards related to communicable diseases

5521

44262

1.33

63.70

1.4

1.3

1.19

1.73

u/ml

3.85

2169

12028

Viral hepatitis, IBD co-morbidity

636

3245

2.26

63.68

1.3

1.2

1.66

2.56

u/ml

0.77

119

939

Chronic kidney disease

2454

17420

1.49

63.65

1.3

2.30

1.96

u/ml

0.36

591

4346

Childhood asthma (age<16), excluding more controls

2377

13540

1.56

63.45

1.4

1.3

1.90

1.92

u/ml

0.03

627

3834

Vascular disorders of the intestines

580

2855

2.33

63.30

1.3

1.2

1.46

1.96

u/ml

0.57

132

743

Postmenopausal bleeding

3058

12349

1.47

63.02

1.3

1.2

1.64

1.75

u/ml

0.14

712

3251

Childhood asthma (age<16)

2377

13566

1.55

62.92

1.4

1.3

1.90

1.93

u/ml

0.03

627

3834

Maternal care for other conditions predominantly related to pregnancy

3148

23548

1.46

62.69

1.3

1.26

1.46

u/ml

0.55

967

6937

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6101

31277

1.30

62.66

1.3

1.53

1.72

u/ml

0.55

1823

8894

Ulcerative colitis, NAS

1722

11690

1.65

62.64

1.3

1.35

1.85

u/ml

1.26

428

3220

Diseases of arteries, arterioles and capillaries (FINNGEN)

2567

12853

1.49

62.56

1.3

1.2

1.54

2.02

u/ml

0.93

610

3315

Chronic hepatitis, not elsewhere classified

488

2359

2.75

62.11

1.5

1.2

1.31

1.67

u/ml

0.46

116

633

Hyperplasia of prostate

2758

11265

1.46

62.04

1.2

2.13

2.17

u/ml

0.04

674

3004

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

4010

31303

1.38

61.94

1.4

1.3

1.19

1.64

u/ml

2.06

1003

9018

Other shoulder lesions

1123

6935

1.86

61.90

1.4

1.2

1.25

1.84

u/ml

0.77

280

1880

Gastric ulcer

1534

10038

1.65

61.85

1.3

1.2

1.31

1.92

u/ml

1.28

377

2630

Benign neoplasm: Transverse colon

983

5852

1.93

61.65

1.3

1.2

1.03

1.75

u/ml

2.93

223

1464

Unspecified fall

5537

44321

1.31

61.64

1.4

1.3

2.00

1.74

u/ml

0.53

1188

11704

Injuries to the wrist and hand

12971

81593

1.19

61.54

1.3

1.62

1.71

u/ml

0.31

3383

22390

Poisoning by medicine

2888

21565

1.47

61.49

1.4

1.3

1.24

1.70

u/ml

1.56

693

6142

Abnormal involuntary movements

1495

9890

1.70

61.37

1.4

1.3

1.61

1.85

u/ml

0.22

375

2552

Metatarsalgia

1153

7200

1.84

61.24

1.3

1.2

1.65

1.70

u/ml

0.05

263

1917

Inflammatory disease of uterus

2044

14534

1.60

61.11

1.3

1.25

1.53

u/ml

0.58

551

4226

Injuries to the head

14459

82284

1.18

61.01

1.3

1.66

1.72

u/ml

0.19

3707

22535

Elevated blood glucose level

956

5698

1.96

60.85

1.6

1.3

2.64

1.73

u/ml

0.74

231

1471

Meniscus derangement

6178

34275

1.29

60.84

1.3

1.2

1.51

1.83

u/ml

1.24

1642

9420

L04AA Selective immunosuppressants

2545

18637

1.50

60.77

1.3

1.36

1.69

u/ml

0.69

656

5062

Injuries to the elbow and forearm

8800

67236

1.24

60.52

1.3

2.14

1.64

u/ml

1.96

2189

18102

Other noninflammatory disorders of vulva and perineum

1235

7906

1.81

60.25

1.4

1.3

1.67

1.89

u/ml

0.18

313

2188

Convulsions, not elsewhere classified

2826

20712

1.45

59.75

1.4

1.3

1.93

1.99

u/ml

0.07

675

5492

Prurigo nodularis

342

1442

3.26

59.54

1.4

1.2

2.48

1.57

u/ml

0.51

381

Hallux valgus (acquired)

3870

21610

1.38

59.54

1.2

1.55

1.80

u/ml

0.53

937

5874

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

11308

63250

1.20

59.38

1.3

1.46

1.72

u/ml

1.51

3081

17328

Brachial plexus disorders

1234

7938

1.80

59.04

1.4

1.3

1.14

1.69

u/ml

1.73

463

2310

Disorders of parathyroid gland

2076

14490

1.54

58.94

1.3

1.2

1.36

1.68

u/ml

0.60

512

3628

Social phobias

1276

8319

1.80

58.73

1.4

1.3

1.45

1.58

u/ml

0.17

295

2363

Coxarthrosis [arthrosis of hip](FG)

5319

30792

1.30

58.72

1.3

1.2

1.68

1.83

u/ml

0.34

1315

8035

Abnormalities of gait and mobility

1179

7438

1.79

58.71

1.3

1.60

1.86

u/ml

0.33

219

1809

Other acute lower respiratory infections

6217

48662

1.28

58.53

1.4

1.3

1.54

1.79

u/ml

0.89

1574

12968

Lateral epicondylitis

1521

10164

1.66

58.46

1.3

1.2

1.83

2.01

u/ml

0.17

465

2852

Other inflammatory liver diseases

787

4503

2.08

58.43

1.4

1.3

1.10

1.57

u/ml

1.00

178

1213

Injuries to the shoulder and upper arm

9737

69651

1.22

58.13

1.3

1.93

1.70

u/ml

0.71

2549

18722

Carbimazole or st.post thyroidectomy, condition for graves disease

2511

18524

1.49

57.86

1.3

1.88

1.50

u/ml

0.76

623

5111

Exclusions for E4_PCOS_CONSORTIUM

10433

56178

1.22

57.55

1.3

1.35

1.62

u/ml

1.55

2789

15573

Other disorders of patella

2182

15699

1.52

57.26

1.3

1.51

1.92

u/ml

0.80

572

4487

Persons encountering health services for specific procedures, not carried out

982

6019

1.91

57.16

1.4

1.3

1.40

1.52

u/ml

0.08

179

1624

Candidiasis

1603

10959

1.65

57.06

1.3

2.20

1.57

u/ml

0.65

362

2929

Biguanides

11218

59503

1.20

57.00

1.3

1.61

1.74

u/ml

0.45

3003

16382

Pain associated with micturition

1356

8944

1.72

56.85

1.4

1.3

1.74

u/ml

0.00

304

2322

Parodontitis or operation codes

10411

65825

1.21

56.71

1.3

1.66

1.70

u/ml

0.11

2520

18249

Alcohol use disorder, Swedish definition

5817

44053

1.28

56.60

1.3

1.87

1.83

u/ml

0.07

1453

12320

Colonic or urogenital fistula

2914

21945

1.43

56.44

1.3

1.23

1.72

u/ml

1.83

747

6008

Psychotic depression

754

4274

2.05

56.35

1.4

1.3

0.72

1.53

u/ml

5.14

189

1178

Bacterial Sepsis

4138

28857

1.34

56.31

1.3

1.2

2.11

1.83

u/ml

0.44

942

7385

Viral infections characterized by skin and mucous membrane lesions

4792

38463

1.32

56.25

1.4

1.3

1.85

1.76

u/ml

0.17

1253

10412

Parodontitis

10390

65800

1.21

56.00

1.3

1.67

1.70

u/ml

0.10

2512

18243

Gout

2090

13448

1.50

55.90

1.2

2.14

2.07

u/ml

0.06

483

3351

Lichen planus, including avohilmo

1919

13568

1.56

55.82

1.3

1.2

1.53

1.67

u/ml

0.26

525

3515

Oesophageal varices

459

2219

2.56

55.78

1.3

3.22

1.71

u/ml

0.65

570

Autoimmune hyperthyroidism

799

4662

2.04

55.71

1.4

1.2

1.85

1.28

u/ml

0.71

196

1257

Disorders of mineral metabolism

899

5390

1.93

55.60

1.4

1.3

1.21

1.67

u/ml

0.75

230

1381

Other/unspecified synovitis and tenosynovitis

1317

8633

1.70

55.54

1.4

1.2

1.57

1.81

u/ml

0.28

353

2316

Alcoholic liver disease

898

5335

1.89

55.40

1.3

1.2

3.23

2.14

u/ml

0.74

166

1448

Primary biliary cholangitis (PBC)

319

1352

3.28

55.31

1.4

1.2

0.73

1.36

u/ml

1.07

349

Diseases of external ear

3627

28231

1.37

55.25

1.4

1.3

1.75

1.76

u/ml

0.01

823

7531

Vitamin B12 deficiency anaemia

1005

6146

1.81

55.08

1.4

1.2

2.42

1.50

u/ml

0.77

222

1578

Chronic periodontitis, including avohilmo

10335

65761

1.20

55.06

1.3

1.64

1.71

u/ml

0.22

2502

18228

Biological medication for rheuma

1998

14362

1.55

54.47

1.3

1.48

1.70

u/ml

0.32

573

4072

Acute bronchitis

4485

35077

1.32

54.30

1.4

1.3

1.47

1.81

u/ml

1.12

1138

9280

ILD medications: azathioprine

1851

13094

1.56

54.07

1.4

1.3

1.17

1.77

u/ml

2.45

476

3587

Emotional disorders starting during childhood or adolecense, excluding more controls

878

5302

2.04

53.89

1.7

1.5

1.52

2.10

u/ml

0.72

192

1372

Blepharochalasis

2802

21101

1.42

53.88

1.3

1.2

1.38

1.84

u/ml

1.67

686

5319

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2225

16324

1.51

53.71

1.4

1.3

1.25

1.75

u/ml

1.29

535

4639

6250

47417

1.26

53.69

1.3

1.83

1.80

u/ml

0.04

1549

13204

Azathioprine

1851

13111

1.56

53.69

1.4

1.3

1.17

1.81

u/ml

2.66

476

3565

Mental and behavioural disorders due to psychoactive substance use

6671

52429

1.25

53.16

1.3

1.70

1.81

u/ml

0.24

1629

14696

Preparation and fitting of bite rail to mouth

1709

12005

1.60

53.12

1.3

1.03

1.66

u/ml

2.48

486

3367

Other disorders of eye and adnexa

1697

11899

1.60

53.04

1.4

1.3

1.11

1.76

u/ml

2.40

370

3234

Heart failure and antihypertensive medication

2395

11481

1.46

53.04

1.3

1.2

1.95

2.12

u/ml

0.19

595

2947

Injuries to the neck

2746

20764

1.43

52.96

1.4

1.3

1.39

1.74

u/ml

0.83

729

5822

Other or unspecified ileus, impaction or obstruction

1536

10383

1.59

52.96

1.3

1.2

1.54

2.20

u/ml

1.27

406

2737

Abrasion of teeth

3348

19036

1.39

52.81

1.3

1.66

1.77

u/ml

0.20

869

5509

Disorders of ocular muscles, binocular movement, accommodation and refraction

6033

49646

1.27

52.62

1.4

1.3

1.56

1.75

u/ml

0.53

1673

13443

Other and unspecified nerve root and plexus disorders, also in other diseases

2007

14428

1.52

52.45

1.3

1.2

1.70

1.79

u/ml

0.09

432

4031

Type 2 diabetes, definitions combined

11013

56818

1.19

52.28

1.3

1.2

1.56

1.72

u/ml

0.61

2997

15519

Type 2 diabetes, strict (exclude DM1)

11045

57029

1.19

52.18

1.3

1.2

1.56

1.72

u/ml

0.62

3006

15580

Diabetes mellitus in pregnancy

5142

27256

1.32

52.12

1.4

1.3

1.69

1.53

u/ml

0.41

1652

8023

Polyp of the female genital tract

3957

18103

1.36

51.89

1.3

1.26

1.69

u/ml

1.40

988

4988

Other inflammation of eyelid

1464

9995

1.64

51.88

1.3

1.90

1.85

u/ml

0.04

333

2608

Anorexia (incl.atypical)

996

6363

1.89

51.68

1.6

1.3

0.98

1.65

u/ml

2.29

272

1738

Infections with a predominantly sexual mode of transmission

4284

34469

1.33

51.52

1.4

1.3

2.08

1.50

u/ml

1.26

999

10040

Other CVD (FINNGEN)

1110

5524

1.74

51.45

1.3

1.2

1.73

2.05

u/ml

0.22

267

1329

Paroxysmal tachycardia

2698

17148

1.43

51.45

1.3

1.43

1.80

u/ml

1.03

725

4512

Rosacea

1344

9073

1.68

51.13

1.3

1.47

1.64

u/ml

0.23

377

2495

Substance abuse

6422

51128

1.25

51.13

1.3

1.72

1.81

u/ml

0.19

1557

14398

Dermatographic urticaria

925

5791

1.91

51.07

1.4

1.3

1.23

1.46

u/ml

0.35

290

1604

Other metabolic disorders

1609

11247

1.60

50.99

1.4

1.3

1.61

1.44

u/ml

0.28

460

3132

Conjunctivitis (acute, non atopic)

3398

26501

1.37

50.86

1.3

1.96

1.80

u/ml

0.23

839

7193

Iron deficiency anaemia secondary to blood loss (chronic)

1551

10668

1.59

50.84

1.3

1.2

1.73

1.61

u/ml

0.11

376

2778

Psoriasis vulgaris

1985

14325

1.51

50.77

1.3

2.12

1.84

u/ml

0.32

539

3905

Type 2 diabetes, definitions combined, including avohilmo

11141

57203

1.19

50.58

1.3

1.2

1.54

1.71

u/ml

0.73

3034

15665

Arthropathies in other diseases classified elsewhere

441

2186

2.50

50.50

1.6

1.2

1.65

1.91

u/ml

0.18

123

562

Other disorders of veins

4279

34329

1.32

50.47

1.3

1.40

1.68

u/ml

0.77

950

9266

Other problems related to primary support group, including family circumstances

1777

12467

1.59

50.40

1.6

1.4

1.78

1.79

u/ml

0.01

468

3319

Lactose intolerance

473

2452

2.50

50.10

1.5

1.3

1.01

1.88

u/ml

1.57

106

630

Enlarged lymph nodes

1761

12468

1.54

49.98

1.3

1.41

2.01

u/ml

1.80

521

3341

Other diseases of stomach and duodenum

645

3609

2.06

49.86

1.4

1.2

1.46

1.62

u/ml

0.17

141

952

6604

49467

1.24

49.82

1.3

1.84

1.81

u/ml

0.06

1648

13824

Non-rheumatic valve diseases

4585

26883

1.30

49.68

1.3

2.18

1.85

u/ml

0.63

1203

6755

Injuries to the hip and thigh

4589

33874

1.30

49.60

1.3

1.65

1.78

u/ml

0.28

1143

8807

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

5055

41455

1.29

49.59

1.3

1.73

1.67

u/ml

0.09

1289

11716

Abnormal findings on diagnostic imaging of lung

4252

33123

1.31

49.51

1.3

1.2

1.69

1.77

u/ml

0.17

971

8490

Other and unspecified mood [affective] disorders

1040

6727

1.81

49.43

1.4

1.3

0.94

1.56

u/ml

2.07

223

1930

Glomerular disorders in diseases classified elsewhere

1141

7434

1.71

49.28

1.5

1.2

2.52

1.89

u/ml

0.56

309

1942

Ganglion

2498

18782

1.43

49.25

1.3

1.2

1.79

1.80

u/ml

0.02

707

5268

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1490

10342

1.62

49.16

1.4

1.3

1.63

1.42

u/ml

0.34

432

2923

Other and unspecified rosacea

994

6341

1.81

49.12

1.4

1.2

1.61

1.74

u/ml

0.12

277

1755

Hypokalaemia

1172

7691

1.69

48.97

1.4

1.3

1.20

1.79

u/ml

1.23

279

2001

Congenital malformations, deformations and chromosomal abnormalities

7953

65144

1.22

48.81

1.3

1.57

1.70

u/ml

0.41

2142

18180

Tongue abnormality

698

4078

2.04

48.65

1.4

1.3

0.85

1.50

u/ml

2.27

188

1044

Cellulitis

2318

17271

1.45

48.50

1.4

1.3

2.23

1.92

u/ml

0.38

569

4653

Conductive and sensorineural hearing loss

8329

49163

1.21

48.46

1.3

1.67

1.76

u/ml

0.27

2186

12858

Crohn disease (strict definition, all UC cases excluded)

698

4112

2.06

48.43

1.4

1.3

0.82

1.85

u/ml

2.70

177

1113

Renal tubulo-interstitial diseases

10343

68923

1.19

48.31

1.3

1.59

1.69

u/ml

0.33

2625

18530

Other bullous disorders

369

1760

2.75

48.29

1.9

1.3

6.39

1.81

u/ml

3.26

134

475

Suppurative and unspecified otitis media

5197

38013

1.29

48.21

1.4

1.3

2.14

1.63

u/ml

1.34

1331

10678

Barrett oesophagus

472

2414

2.31

48.21

1.3

1.2

2.15

1.83

u/ml

0.18

657

Adrenocortical insufficiency

474

2483

2.43

48.19

1.6

1.3

1.35

1.67

u/ml

0.33

176

642

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

917

5794

1.86

48.16

1.4

1.3

0.89

1.56

u/ml

2.12

228

1584

All influenza

2701

20576

1.40

47.99

1.4

1.3

1.73

1.87

u/ml

0.19

718

5455

Missing teeth due to accident, extraction or parodontitis

1144

7497

1.69

47.89

1.3

1.2

1.18

2.07

u/ml

3.32

315

2028

Valvular heart disease excluding rheumatic fever

4616

27231

1.29

47.83

1.3

2.18

1.87

u/ml

0.58

1208

6837

Other diseases of oesophagus

892

5505

1.80

47.36

1.3

1.2

1.70

1.88

u/ml

0.13

222

1419

Degeneration of macula and posterior pole

3912

25613

1.32

47.33

1.3

1.2

1.64

1.78

u/ml

0.24

962

6137

Infective dermatitis

1213

8090

1.67

47.25

1.4

1.2

1.40

1.90

u/ml

1.31

376

2133

Sensorineural hearing loss

7662

45505

1.22

47.03

1.3

1.70

1.75

u/ml

0.13

1984

11836

Crohn disease (strict definition, require KELA)

866

5440

1.88

46.78

1.4

1.3

0.90

1.58

u/ml

1.97

217

1488

Other abnormal uterine and vaginal bleeding

2740

14910

1.41

46.78

1.3

1.52

1.73

u/ml

0.35

652

3994

Other hammer toe(s) (acquired)

1717

11446

1.52

46.76

1.2

1.54

2.08

u/ml

0.98

373

2858

Graves disease, strict definition

1288

8818

1.67

46.76

1.4

1.3

2.09

1.62

u/ml

0.52

340

2494

Transient ischemic attack

4734

31893

1.28

46.74

1.3

1.2

1.35

1.75

u/ml

1.93

1209

8013

Other symptoms and signs involving the urinary system

1008

6463

1.74

46.51

1.3

1.2

1.15

1.92

u/ml

2.19

398

1688

Dental caries 2 and operation codes, only avohilmo

9893

53431

1.20

46.48

1.3

1.47

1.73

u/ml

1.25

2419

14750

Suicide or other Intentional self-harm

3048

23807

1.38

46.37

1.4

1.3

1.38

1.66

u/ml

0.67

714

6756

Gonarthrosis,primary

9217

49931

1.20

46.18

1.2

1.72

1.75

u/ml

0.09

2443

13271

Acute pancreatitis

1807

12979

1.50

46.18

1.3

1.81

1.99

u/ml

0.22

469

3427

Sequelae of external causes of morbidity and mortality

2525

19185

1.41

46.00

1.3

1.48

1.77

u/ml

0.49

717

5050

Superficial injury of lower leg

2936

22837

1.38

45.90

1.4

1.3

1.89

1.67

u/ml

0.32

769

6229

Glomerular diseases

1781

12822

1.51

45.84

1.5

1.3

2.08

1.97

u/ml

0.10

495

3337

Covid-19 suspected case

2733

21132

1.40

45.76

1.3

1.59

1.66

u/ml

0.09

787

5902

Cutaneous abscess, furuncle and carbuncle

2863

22174

1.38

45.76

1.4

1.3

1.95

1.84

u/ml

0.14

730

6173

Neuromuscular dysfunction of bladder

925

5849

1.78

45.65

1.3

1.2

1.46

1.66

u/ml

0.22

194

1552

Crohn disease (strict definition, require KELA, min 2 HDR)

848

5337

1.88

45.46

1.4

1.3

0.90

1.60

u/ml

2.04

217

1455

Acute renal failure

1697

12073

1.50

45.38

1.3

1.2

2.11

1.96

u/ml

0.11

378

3060

Other symptoms and signs involving the circulatory and respiratory systems

736

4415

1.91

45.21

1.4

1.3

1.68

1.78

u/ml

0.06

212

1123

Benign paroxysmal vertigo

2887

22413

1.38

45.07

1.3

1.80

1.69

u/ml

0.15

731

5871

Lichen planus

1323

9096

1.61

44.89

1.3

1.2

1.45

1.70

u/ml

0.45

374

2355

Endometriosis of ovary

2121

15792

1.46

44.83

1.3

1.18

1.68

u/ml

1.69

550

4412

Ischaemic heart disease, wide definition

7778

41478

1.21

44.81

1.3

1.2

1.47

1.82

u/ml

1.67

2103

10765

Diabetic neuropathy

1096

7235

1.70

44.59

1.6

1.3

1.67

1.73

u/ml

0.07

311

1982

Other CVD

1559

10955

1.53

44.58

1.3

1.2

1.61

1.71

u/ml

0.08

361

2746

Spondyloarthritis

1945

14272

1.47

44.23

1.3

1.36

1.81

u/ml

0.92

525

3966

Fracture of forearm

6533

51840

1.23

44.19

1.3

2.00

1.64

u/ml

1.05

1595

13796

Plantar fascial fibromatosis

1080

7143

1.69

44.15

1.3

1.2

1.80

1.70

u/ml

0.08

263

1928

Dysplasia of cervi uteri

3245

19811

1.36

44.13

1.3

1.66

1.61

u/ml

0.08

947

5656

Disorders of muscles

1070

7055

1.68

43.80

1.3

1.2

2.57

1.96

u/ml

0.45

280

1865

Speech and linguistic disorders, excluding more controls

1206

7770

1.67

43.65

1.5

1.4

2.23

1.97

u/ml

0.19

273

2030

Other specified and unspecified personality disorders

1171

7951

1.67

43.62

1.4

1.3

0.94

1.59

u/ml

2.76

293

2255

Keratitis

3890

31418

1.31

43.51

1.3

1.84

1.69

u/ml

0.27

1139

8575

Spondylopathies (FG)

1635

11743

1.52

43.46

1.3

1.27

1.86

u/ml

1.34

448

3297

Hypotension

1298

8850

1.58

43.43

1.3

1.2

1.58

1.64

u/ml

0.04

308

2195

Hernia of abdominal wall

4445

36334

1.28

43.43

1.3

1.72

1.75

u/ml

0.05

1146

9756

Superficial injury of wrist and hand

2486

19121

1.41

43.08

1.4

1.3

1.68

1.74

u/ml

0.08

617

5268

Unspecified haematuria

3641

24871

1.31

42.70

1.3

1.2

1.44

1.88

u/ml

1.66

847

6469

Small fibre neuropathy

328

1561

2.71

42.68

1.5

1.2

0.71

1.34

u/ml

2.48

406

Cerebrovascular diseases (FINNGEN)

3520

19995

1.32

42.67

1.3

1.2

1.38

1.77

u/ml

1.38

925

5462

Other follicular disorders

890

5732

1.80

42.61

1.4

1.3

1.40

1.57

u/ml

0.16

278

1603

Dislocation, sprain and strain of joints and ligaments at neck level

1927

14334

1.48

42.59

1.4

1.3

1.41

1.62

u/ml

0.31

534

4032

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

7421

52020

1.22

42.56

1.3

1.50

1.56

u/ml

0.18

2229

14619

Fracture of shoulder and upper arm

3773

30405

1.31

42.44

1.3

2.21

1.76

u/ml

0.70

894

7884

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

997

12692

0.62

42.21

1.2

1.98

1.87

u/ml

0.09

205

3227

Unspecified mental disorder

4966

41258

1.26

42.20

1.3

1.55

1.71

u/ml

0.34

1291

11706

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

770

4743

1.83

42.15

1.3

1.2

2.71

1.57

u/ml

0.82

191

1198

Glaucoma

5189

37825

1.25

42.00

1.3

1.2

1.74

1.69

u/ml

0.10

1428

9417

Otitis externa

2452

18850

1.40

41.90

1.4

1.3

1.53

1.77

u/ml

0.45

564

5115

TMD related pain

529

3040

2.23

41.85

1.4

1.3

0.65

1.69

u/ml

3.66

135

826

Sulfasalazine

3237

25715

1.33

41.63

1.3

1.24

1.80

u/ml

2.62

853

7101

Tumor necrosis factor alpha inhibitors

1767

13021

1.50

41.58

1.3

1.57

1.73

u/ml

0.20

513

3685

Problems related to lifestyle

1218

8367

1.62

41.57

1.4

1.3

1.19

1.78

u/ml

1.08

335

2258

Mental and behavioural disorders due to alcohol

5346

43450

1.24

41.43

1.3

1.56

1.83

u/ml

0.82

1344

12153

Adjustment and management of implanted device

1522

10793

1.51

41.39

1.3

1.2

2.16

1.88

u/ml

0.19

276

2715

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

11454

63351

1.17

41.30

1.3

1.66

1.75

u/ml

0.30

2880

17346

11454

63351

1.17

41.30

1.3

1.66

1.75

u/ml

0.30

2880

17346

Dermatitis herpetiformis

265

1187

3.06

40.93

2.1

1.3

7.60

1.66

u/ml

3.51

106

308

Other disorders of adrenal gland

586

3453

2.07

40.86

1.6

1.4

1.35

1.85

u/ml

0.72

199

886

Striking against or struck by other objects

3785

30712

1.30

40.74

1.4

1.3

2.02

1.76

u/ml

0.49

848

8470

Otalgia

987

6596

1.73

40.50

1.4

1.01

1.76

u/ml

2.89

210

1680

Benign neoplasm: Descending colon

625

3697

1.94

40.32

1.3

2.26

1.81

u/ml

0.17

164

967

Ocular pain

998

6691

1.71

40.11

1.4

1.3

1.02

1.59

u/ml

1.55

243

1822

Appendectomy

8186

68533

1.19

39.97

1.3

1.63

1.66

u/ml

0.06

2332

19129

Psoriatic and enteropathic arthropathies

1280

8928

1.58

39.95

1.3

1.2

1.40

1.97

u/ml

0.73

342

2486

Sequelae with surgical and medical care as external cause

1941

14503

1.44

39.94

1.3

1.45

1.81

u/ml

0.51

549

3770

6-mercaptopurine

461

2560

2.28

39.89

1.4

1.3

1.09

1.86

u/ml

0.68

125

695

Ischemic heart diseases

7885

42519

1.20

39.87

1.3

1.2

1.44

1.82

u/ml

2.06

2252

10969

Acute appendicitis, no complications

6851

58636

1.21

39.83

1.3

1.62

1.70

u/ml

0.19

1960

16590

Bulimia nervosa (incl. atypical)

612

3741

2.10

39.81

1.5

1.3

0.81

1.75

u/ml

2.62

161

1059

Endometriosis ASRM stages 1,2

2407

18729

1.41

39.65

1.3

1.34

1.53

u/ml

0.41

681

5397

Lesion of ulnar nerve

1381

9765

1.54

39.47

1.3

1.2

1.74

2.03

u/ml

0.29

389

2670

Other disorders of penis

835

5306

1.73

39.24

1.3

1.91

2.30

u/ml

0.32

190

1377

Malignant neoplasm of respiratory system and intrathoracic organs

729

10752

0.59

39.20

1.2

2.30

1.88

u/ml

0.30

139

2665

Benign neoplasm: Descending colon

625

3727

1.92

39.18

1.3

1.2

2.26

1.43

u/ml

0.37

164

964

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1419

10104

1.53

39.18

1.4

1.2

1.57

1.83

u/ml

0.44

289

2659

Schizophrenia or delusion, excluding more controls

3435

27430

1.31

39.13

1.4

1.3

1.91

1.75

u/ml

0.23

887

8014

Diplopia

1323

9325

1.56

39.11

1.3

1.96

1.81

u/ml

0.09

348

2449

Disorders of breast

6292

49906

1.23

39.07

1.3

1.36

1.51

u/ml

0.42

1702

13755

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

833

10772

0.61

38.93

1.2

1.92

1.81

u/ml

0.09

167

2747

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4444

36663

1.26

38.84

1.3

1.62

1.84

u/ml

0.49

1126

10240

Neuralgia and neuritis, unspecified

577

3389

1.98

38.78

1.4

1.2

0.79

1.54

u/ml

2.66

141

890

Ascites

656

3954

1.86

38.71

1.3

1.2

3.99

1.91

u/ml

0.96

153

1052

Intestinal stricture

2743

21496

1.34

38.70

1.3

1.77

1.72

u/ml

0.06

691

5549

Disorders of continuity of bone

1091

7468

1.64

38.66

1.4

1.3

1.46

1.73

u/ml

0.38

255

1984

Glucosamine medication

4605

30406

1.26

38.64

1.3

1.2

1.29

1.75

u/ml

1.76

1095

7493

Other noninflammatory disorders of uterus, except cervix

2360

12337

1.39

38.54

1.3

1.2

1.23

1.69

u/ml

1.32

617

3231

Fracture of lower leg, including ankle

6171

52400

1.22

38.54

1.3

2.03

1.65

u/ml

1.04

1560

14120

Mixed connective tissue disease

778

4979

1.82

38.53

1.4

1.3

1.99

1.50

u/ml

0.40

206

1336

Psoriatic arthropathies

1073

7281

1.62

38.41

1.3

1.2

1.49

2.07

u/ml

0.62

299

2008

Rheumatoid arthritis, including avohilmo

4015

32969

1.28

38.24

1.3

1.17

1.73

u/ml

3.30

1067

8708

Other disorders of bone

2289

17657

1.39

38.17

1.4

1.3

1.63

1.73

u/ml

0.13

602

4854

Diseases of appendix

9144

73131

1.18

38.08

1.3

1.71

1.66

u/ml

0.11

2576

20364

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1052

15364

0.65

38.02

1.2

1.35

1.84

u/ml

0.99

291

4020

Other hearing loss

2307

17375

1.37

37.84

1.3

1.2

1.45

1.84

u/ml

1.14

582

4359

Other diseases of pancreas

714

4450

1.81

37.57

1.4

1.2

1.70

1.75

u/ml

0.03

181

1149

Appendicitis, broad definition

9068

72804

1.18

37.52

1.3

1.70

1.66

u/ml

0.09

2560

20282

Nummular dermatitis

810

5207

1.74

37.50

1.4

1.2

1.71

1.68

u/ml

0.02

229

1351

Contact with and exposure to communicable diseases

4530

37763

1.27

37.45

1.4

1.3

1.18

1.68

u/ml

3.16

2008

10244

False labour

4659

24484

1.28

37.38

1.3

1.25

1.55

u/ml

1.19

1451

7171

Acute gastritis

733

4586

1.78

37.33

1.3

1.2

2.41

1.94

u/ml

0.27

207

1221

SLE (Finngen)

438

2419

2.20

37.17

1.4

1.2

1.32

1.39

u/ml

0.04

102

636

Atrophic disorders of skin

1612

11904

1.49

37.08

1.3

1.75

1.61

u/ml

0.17

432

3190

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2497

28018

0.75

36.92

1.2

1.3

1.50

1.66

u/ml

0.26

638

7370

Hypermobility syndrome

805

5303

1.81

36.88

1.4

1.3

0.89

1.43

u/ml

0.76

261

1487

Other specified/unspecified systemic involvement of connective tissue

703

4438

1.85

36.78

1.4

1.3

2.14

1.54

u/ml

0.47

185

1186

L04AD Calcineurin inhibitors

1190

8364

1.59

36.78

1.4

1.3

1.45

1.97

u/ml

0.68

287

2140

Acute pancreatitis (for exclusion)

1807

13478

1.43

36.76

1.3

1.81

2.00

u/ml

0.24

469

3551

Hypoparathyroidism

437

2432

2.21

36.71

1.4

1.3

0.86

1.74

u/ml

1.97

130

618

Charcot foot

221

948

3.08

36.68

1.7

1.2

1.73

1.13

u/ml

0.57

258

Vulvovaginal ulceration/inflammation in other diseases

857

5720

1.77

36.68

1.4

1.3

1.22

1.51

u/ml

0.40

226

1613

Retention of urine

2692

17802

1.33

36.63

1.3

1.2

1.60

1.86

u/ml

0.57

659

4565

Sequelae of injuries, of poisoning and of other consequences of external causes

2487

19455

1.36

36.63

1.3

2.43

1.71

u/ml

0.94

565

5403

Fracture of femur

2134

14807

1.38

36.60

1.3

1.2

1.57

1.76

u/ml

0.30

529

3615

Seborrhoeic dermatitis

949

6346

1.65

36.52

1.4

1.3

1.46

1.79

u/ml

0.51

262

1650

Substance use, excluding alcohol

2233

17262

1.39

36.50

1.4

1.3

1.95

1.81

u/ml

0.14

500

4910

Dissociative [conversion] disorders

571

3459

2.01

36.40

1.4

1.3

2.24

1.50

u/ml

0.42

174

959

Any event in hilmo or specialist outpatient

129

188

4.34

36.23

1.3

1.1

1.05

1.87

u/ml

0.41

Oral lichen ruber planus wide, hypothyreosis or thyroxin

603

3682

1.94

36.20

1.4

1.3

1.49

1.59

u/ml

0.09

161

942

Ventral hernia

2250

17385

1.37

35.85

1.3

1.68

1.77

u/ml

0.10

573

4663

Stomatitis and related lesions

936

6289

1.66

35.77

1.4

1.3

1.82

1.90

u/ml

0.07

211

1704

Childhood allergy (age < 16)

2671

17598

1.37

35.74

1.5

1.4

2.12

1.82

u/ml

0.50

661

4608

Glaucoma suspect

3307

26775

1.30

35.68

1.3

1.2

1.71

1.75

u/ml

0.07

959

6747

Bacterial infection, other or unspecified

5006

37960

1.23

35.68

1.3

1.62

1.74

u/ml

0.25

1085

9884

Flat foot [pes planus] (acquired)

1029

7057

1.62

35.52

1.3

1.2

1.74

1.93

u/ml

0.14

284

1852

Other protozoal intestinal diseases

223

996

3.17

35.35

1.5

1.3

2.80

2.10

u/ml

0.15

252

Secondary hypertension

806

5174

1.70

35.32

1.4

1.3

2.14

2.02

u/ml

0.07

198

1281

Emotional disorders and disorders of social functioning with onset specific to childhood

951

6512

1.74

35.28

1.7

1.5

1.48

1.93

u/ml

0.57

203

1589

Agoraphobia

491

2886

2.11

35.23

1.4

1.3

1.53

1.33

u/ml

0.17

834

Unspecified urinary incontinence

953

6466

1.65

35.17

1.4

1.3

1.58

1.47

u/ml

0.11

121

1652

2135

14450

1.37

35.01

1.2

1.76

1.86

u/ml

0.11

540

3309

Disorders of psychological development

1782

12559

1.46

35.00

1.5

1.4

2.04

2.06

u/ml

0.01

404

3167

Hyperparathyroidism

1680

12349

1.44

35.00

1.3

1.2

1.49

1.60

u/ml

0.13

394

3104

Gout, idiopatic and unspecified

1777

13276

1.41

34.84

1.2

2.34

1.93

u/ml

0.38

408

3323

Fracture of foot, except ankle

2778

22212

1.33

34.79

1.4

1.3

2.08

1.74

u/ml

0.50

685

6219

Polymyalgia rheumatica

1077

7424

1.57

34.73

1.3

1.2

1.13

1.62

u/ml

1.67

263

1831

Intestinal adhesions without obstruction

725

4595

1.74

34.72

1.3

1.2

1.98

1.83

u/ml

0.10

158

1243

Localized swelling, mass and lump of skin and subcutaneous tissue

3244

26340

1.30

34.55

1.3

1.37

1.80

u/ml

1.77

797

7095

Other abnormal immunological findings in serum

306

1573

2.65

34.51

1.8

1.4

6.57

2.04

u/ml

2.58

405

Acute suppurative otitis media

3838

29746

1.28

34.43

1.4

1.3

2.39

1.64

u/ml

1.62

1004

8341

Atypical facial pain

603

3724

1.89

34.43

1.4

1.2

1.69

1.53

u/ml

0.08

155

985

Acute appendicitis

8486

70441

1.17

34.30

1.3

1.73

1.67

u/ml

0.15

2405

19705

Lactose intolerance, other/unspecified

390

2149

2.27

34.28

1.5

1.3

1.08

1.66

u/ml

0.76

548

Alcohol use disorder, ICD-based

4085

33887

1.25

34.27

1.3

1.63

1.82

u/ml

0.39

1046

9454

Pacemaker

2477

18857

1.33

34.17

1.3

1.2

2.12

1.87

u/ml

0.29

626

4535

Postprocedural disorders of nervous system

982

6802

1.65

34.00

1.4

1.3

1.49

1.45

u/ml

0.04

295

1921

Alcohol abuse, main dg, excluding more controls

1495

10978

1.46

33.97

1.3

1.20

1.89

u/ml

3.07

347

3153

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3396

27823

1.29

33.95

1.4

1.3

1.64

1.68

u/ml

0.07

891

7812

Vitamin deficiency, wide

547

3298

1.93

33.79

1.4

1.3

2.12

1.64

u/ml

0.23

143

868

Vitamin deficiency

547

3298

1.93

33.79

1.4

1.3

2.12

1.64

u/ml

0.23

143

868

Other female pelvic inflammatory diseases

1963

15158

1.41

33.63

1.3

0.97

1.55

u/ml

2.30

468

4190

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

438

2467

2.05

33.43

1.3

1.2

0.89

1.88

u/ml

2.70

626

Acne

1541

11566

1.49

33.41

1.5

1.4

1.55

1.75

u/ml

0.32

449

3146

Correction of physiology of bite - demanding therapy visit

892

6082

1.68

33.39

1.4

1.3

0.66

1.54

u/ml

6.91

294

1688

Gout, FINNGEN

2090

16059

1.36

33.33

1.2

2.14

1.87

u/ml

0.27

483

4054

1524

10582

1.44

33.24

1.3

1.2

1.80

1.82

u/ml

0.02

391

2391

Disorders of refraction and accommodation

3298

26946

1.30

33.22

1.4

1.3

1.99

1.80

u/ml

0.25

870

7238

D07AA Corticosteroids, weak (group I)

1992

15418

1.40

33.15

1.4

1.3

2.23

1.78

u/ml

0.55

538

4133

Malignant neoplasm of bronchus and lung

604

9088

0.59

32.99

1.2

2.20

1.80

u/ml

0.26

110

2219

Certain disorders involving the immune mechanism

1971

15189

1.39

32.95

1.3

2.10

1.81

u/ml

0.32

498

4110

Kela-code for severe mental illness

4276

35865

1.25

32.87

1.3

1.63

1.67

u/ml

0.05

1151

10133

Nail disorders

928

6354

1.64

32.86

1.4

1.3

1.33

1.75

u/ml

0.86

259

1699

Scoliosis

1103

7831

1.58

32.73

1.4

1.3

1.58

1.70

u/ml

0.12

280

2022

Early onset COPD, excluding more controls

1791

13526

1.40

32.72

1.3

1.2

1.63

2.06

u/ml

0.73

415

3702

Reactive arthropathies

946

6474

1.61

32.65

1.3

1.86

2.14

u/ml

0.25

242

1741

Dermatophytosis

1205

8611

1.52

32.64

1.4

1.3

2.27

1.90

u/ml

0.33

351

2246

Drug-induced osteoporosis with pathological fracture

207

923

3.10

32.60

1.4

1.2

0.83

1.52

u/ml

0.95

233

Hypopituitarism

798

5314

1.70

32.59

1.4

1.21

2.05

u/ml

1.87

235

1330

Combinations of oral blood glucose lowering drugs

2400

18900

1.33

32.56

1.2

1.61

1.93

u/ml

0.51

667

4951

Hypertrophy of breast in women and men

2335

18494

1.36

32.45

1.3

1.05

1.59

u/ml

3.06

712

5233

Acute tubulo-interstitial nephritis

6962

53784

1.19

32.34

1.3

1.43

1.70

u/ml

1.22

1783

14268

Other complications of surgical and medical care, not elsewhere classified

1075

7585

1.57

32.31

1.4

1.3

1.33

1.74

u/ml

0.46

292

2022

Redundant prepuce, phimosis and paraphimosis

1761

13235

1.39

32.19

1.3

1.87

1.91

u/ml

0.05

493

3739

Chronic periodontitis

1289

9310

1.48

32.05

1.3

1.2

2.19

2.00

u/ml

0.16

240

2562

Other and unspecified visual disturbances

1006

7031

1.59

31.90

1.3

2.83

1.63

u/ml

0.85

222

1847

Gout, unspecified

1457

10710

1.44

31.90

1.2

2.27

2.00

u/ml

0.21

330

2686

Other and unspecified tonsillitis

4573

32816

1.24

31.80

1.4

1.3

1.60

1.77

u/ml

0.43

1296

9293

Diseases of arteries, arterioles and capillaries

6053

38839

1.20

31.78

1.3

1.2

1.74

1.77

u/ml

0.05

1481

9981

Disorders of calcium metabolism

635

4024

1.79

31.75

1.3

1.18

1.54

u/ml

0.43

163

1027

Coronary atherosclerosis

6322

35133

1.20

31.70

1.3

1.2

1.55

1.87

u/ml

1.18

1658

8721

Other disorders of kidney and ureter

1153

8219

1.52

31.67

1.3

2.13

1.90

u/ml

0.16

251

2117

Other noninflammatory disorders of vagina

926

6385

1.62

31.65

1.3

1.57

1.66

u/ml

0.09

245

1710

Gout, strict definition

1250

8971

1.48

31.64

1.2

2.20

2.04

u/ml

0.12

282

2237

Enterocolitis due to Clostridium difficile

951

6530

1.58

31.55

1.3

1.2

1.56

1.50

u/ml

0.04

214

1667

Oesophagitis

511

3055

1.89

31.37

1.3

1.2

1.58

1.95

u/ml

0.45

114

801

Other/unspecified enthesopathies of lower limb, excluding foot

799

5346

1.67

31.31

1.4

1.3

0.88

1.90

u/ml

5.02

203

1452

Coagulation defects, purpura and other haemorrhagic conditions

1995

15512

1.38

31.26

1.4

1.3

2.03

1.80

u/ml

0.30

512

4160

Explicit Sepsis

4052

32464

1.24

31.22

1.3

1.78

1.80

u/ml

0.03

1043

8430

Excessive vomiting in pregnancy

1138

8239

1.56

31.16

1.4

1.3

1.59

1.60

u/ml

0.01

321

2363

Other bursopathies

1191

8539

1.50

31.10

1.3

1.2

1.69

2.06

u/ml

0.45

305

2217

Other/unspecified enthesopathies, not elsewhere classified

854

5767

1.62

31.06

1.3

1.2

1.29

1.98

u/ml

1.39

227

1528

Cholangitis (primary sclerosing, PSC)

594

3714

1.80

30.92

1.4

1.3

1.82

1.95

u/ml

0.08

140

946

Disorder of lipoprotein metabolism, unspecified

1111

7862

1.51

30.91

1.3

1.2

1.70

1.89

u/ml

0.19

271

2027

Nonalcoholic steatohepatitis

134

507

4.30

30.84

1.4

1.3

1.00

2.16

u/ml

0.69

134

Complications of internal orthopaedic prosthetic devices, implants and grafts

1931

14909

1.37

30.83

1.3

1.2

1.65

1.88

u/ml

0.31

480

3750

Erysipelas

5185

40395

1.21

30.61

1.3

1.2

1.69

1.73

u/ml

0.08

1350

10700

Alopecia areata

381

2175

2.21

30.53

1.5

1.3

2.49

1.75

u/ml

0.24

109

577

Open wound of head

5263

44402

1.21

30.45

1.3

1.96

1.87

u/ml

0.17

1302

11878

Other viral diseases

3667

30548

1.26

30.35

1.4

1.3

1.42

1.82

u/ml

1.32

1023

8293

Abnormal findings on diagnostic imaging of other body structures

1282

9410

1.48

30.25

1.3

1.43

1.62

u/ml

0.25

342

2514

Acne vulgaris

1211

8913

1.53

30.10

1.5

1.4

1.50

1.69

u/ml

0.28

364

2433

Other diseases of jaws

737

4882

1.68

30.07

1.4

1.2

1.47

1.83

u/ml

0.37

191

1339

Adalimumab

1071

7678

1.55

30.07

1.3

1.52

1.69

u/ml

0.15

298

2142

Superficial injury of thorax

1467

10967

1.44

30.06

1.3

1.74

1.81

u/ml

0.06

372

2896

Palmar fascial fibromatosis [Dupuytren]

1136

8074

1.49

30.01

1.3

1.2

2.33

2.26

u/ml

0.04

255

2017

Rash and other nonspecific skin eruption

1059

7550

1.55

29.98

1.4

1.3

2.49

1.86

u/ml

0.53

308

1969

Cluster headache, wide

470

2817

1.95

29.92

1.4

1.2

1.01

1.74

u/ml

1.41

126

786

Other disorders starting during childhood or adolecense, excluding more controls

785

5176

1.71

29.89

1.6

1.5

2.09

u/ml

0.00

176

1288

Endometriosis of rectovaginal septum and vagina

912

6341

1.60

29.88

1.3

1.06

1.75

u/ml

1.52

264

1701

Conduction disorders

2574

17104

1.31

29.74

1.3

1.92

1.91

u/ml

0.01

619

4221

Ulcerative proctitis

724

4824

1.70

29.65

1.3

1.98

1.62

u/ml

0.18

166

1345

Other endocrine disorders

779

5136

1.72

29.61

1.5

1.6

1.06

2.47

u/ml

4.06

184

1144

Anomalies of dental arch relationship, including avohilmo

2593

18887

1.32

29.53

1.4

1.77

1.81

u/ml

0.05

673

5087

Varicose veins

6424

42208

1.18

29.49

1.3

1.2

1.44

1.70

u/ml

1.06

1834

11139

Diabetic nephropathy, excluding more controls

1426

8886

1.45

29.48

1.6

1.3

2.11

1.54

u/ml

0.94

433

2328

Angina pectoris

5400

31257

1.20

29.28

1.3

1.2

1.25

1.90

u/ml

4.99

1498

7618

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

957

6739

1.57

29.13

1.4

1.3

1.44

1.47

u/ml

0.03

244

1792

Oral leukoplakia and related diseases, including avohilmo

851

5850

1.61

29.04

1.3

1.2

1.12

1.71

u/ml

1.40

192

1555

Thyroiditis

838

5790

1.64

28.97

1.4

1.3

1.90

1.54

u/ml

0.27

227

1564

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3311

27462

1.27

28.93

1.3

1.84

1.70

u/ml

0.22

1125

7427

Colectomy operation

1464

10993

1.42

28.83

1.3

1.2

2.35

1.86

u/ml

0.39

354

2823

Oral lichen ruber planus, including avohilmo

636

4154

1.76

28.70

1.3

1.2

2.06

1.54

u/ml

0.37

180

1117

Emotional disorders starting during childhood or adolescence

886

6274

1.67

28.60

1.7

1.5

1.55

1.95

u/ml

0.46

194

1498

Female infertility, associated with anovulation

1157

8504

1.52

28.46

1.3

1.17

1.63

u/ml

1.17

456

2550

Other Crohn's disease

823

5674

1.63

28.42

1.3

0.79

1.67

u/ml

4.87

189

1563

Ankylosing spondylitis

911

6351

1.56

28.33

1.3

1.17

1.90

u/ml

1.52

230

1737

Oxycodone

2995

23709

1.27

28.20

1.3

1.2

1.39

1.83

u/ml

1.42

814

6226

Oligomenorrhoea

512

3217

1.89

28.12

1.4

1.3

1.80

1.68

u/ml

0.05

142

876

Other bacterial diseases

10669

66364

1.14

28.08

1.3

1.73

1.75

u/ml

0.06

2597

18083

Seropositive rheumatoid arthritis

2498

20093

1.30

28.06

1.3

1.2

1.11

1.79

u/ml

3.48

654

5296

Gluteal tendinitis

418

2472

1.99

28.00

1.3

1.2

1.91

1.69

u/ml

0.11

639

Hypertrophy of breast

2111

16852

1.35

27.99

1.3

1.02

1.62

u/ml

3.16

633

4786

Abnormal findings in secretions and smears from cervix uteri vagina vulva

6601

45628

1.19

27.95

1.3

1.48

u/ml

0.02

1956

13015

Lichen sclerosus et atrophicus

1051

7588

1.53

27.94

1.3

1.52

1.75

u/ml

0.24

291

1995

Drug-induced hypoglycaemia without coma

206

966

2.74

27.91

1.8

1.2

2.50

1.30

u/ml

0.46

258

Cluster headache, strict

438

2631

1.95

27.80

1.4

1.2

1.03

1.80

u/ml

1.35

115

739

Ethmoidectomy

1348

10114

1.44

27.58

1.3

1.77

1.83

u/ml

0.05

365

2810

Herpesviral [herpes simplex] infections

1263

9403

1.46

27.53

1.3

1.83

1.74

u/ml

0.08

340

2577

Seronegative rheumatoid arthritis

1177

8629

1.47

27.50

1.3

1.2

1.63

1.84

u/ml

0.21

302

2278

Nontoxic multinodular goitre

1946

15327

1.35

27.35

1.3

1.2

1.14

1.53

u/ml

1.38

531

3907

Fracture at wrist and hand level

3723

31332

1.24

27.33

1.3

1.81

1.74

u/ml

0.10

939

8701

Autoimmune hepatitis

132

527

3.88

27.24

1.5

1.2

1.18

0.74

u/ml

0.87

142

Other benign neoplasms of skin

3633

30513

1.24

27.22

1.3

1.59

1.70

u/ml

0.20

894

8055

Superficial injury of head

2332

18755

1.31

27.17

1.3

1.29

1.82

u/ml

2.55

516

4988

Misadventures to patients during surgical and medical care

1386

10456

1.43

27.09

1.3

1.24

1.71

u/ml

1.04

323

2813

Acute pharyngitis

1874

14666

1.36

27.02

1.4

2.20

1.87

u/ml

0.38

501

3967

Speech therapy

2647

21619

1.29

26.86

1.3

1.78

u/ml

0.00

503

5775

Type of accident

3033

25145

1.27

26.70

1.3

1.76

1.74

u/ml

0.04

1038

6768

Fall on and from stairs and steps

2556

20821

1.29

26.69

1.3

2.15

1.77

u/ml

0.47

520

5569

Arthropathic psoriasis

1144

8411

1.48

26.69

1.3

1.56

1.82

u/ml

0.24

311

2255

Iridocyclitis

2307

18589

1.31

26.64

1.3

1.73

1.76

u/ml

0.04

662

4989

AV-block

1306

8781

1.42

26.64

1.3

1.2

1.99

1.88

u/ml

0.10

310

2115

Anankastic personality disorder

503

3192

1.86

26.54

1.4

1.3

1.30

1.41

u/ml

0.08

126

890

Superficial injury of abdomen, lower back and pelvis

1637

12684

1.38

26.54

1.4

1.3

1.52

1.75

u/ml

0.35

430

3415

Nasal polyp

1712

13271

1.36

26.50

1.3

1.2

2.01

1.92

u/ml

0.07

437

3668

Other specified/unspecified inflammatory spondylopathies

580

3772

1.75

26.43

1.3

1.66

1.62

u/ml

0.02

181

1074

Superficial injury of hip and thigh

1337

10035

1.42

26.30

1.3

1.93

1.69

u/ml

0.23

326

2594

Autoimmune thyroiditis

279

1519

2.38

26.30

1.4

1.3

3.29

1.46

u/ml

0.71

388

Presbycusis

929

6486

1.50

26.25

1.3

1.2

1.65

1.61

u/ml

0.04

204

1496

Other and unspecified follicular disorders

440

2687

1.91

26.24

1.4

1.2

1.15

1.58

u/ml

0.48

141

766

Umbilical hernia

2454

19892

1.29

26.22

1.3

1.86

1.89

u/ml

0.03

650

5494

Haemorrhage in early pregnancy

3646

30164

1.25

26.16

1.3

1.28

1.48

u/ml

0.54

1042

8515

Other specified/unspecified soft tissue disorders

497

3101

1.80

26.12

1.4

1.2

0.82

1.62

u/ml

2.72

137

777

Presence of cardiac and vascular implants and grafts

3554

22470

1.23

26.06

1.3

1.2

1.95

1.93

u/ml

0.02

796

5488

ILD, hospital admissions

1144

8388

1.45

25.98

1.3

1.2

1.07

1.68

u/ml

3.18

290

2071

Sleep disorders, other/unspecified

455

2841

1.92

25.91

1.5

1.3

1.31

1.64

u/ml

0.33

102

783

Cardiodefibrillation

2764

22625

1.27

25.88

1.3

1.2

1.84

1.87

u/ml

0.04

732

5550

Flatulence and related conditions

146

613

3.23

25.83

1.4

1.3

0.56

1.29

u/ml

2.48

156

FESS (DNB20)

1296

9769

1.43

25.77

1.3

1.79

1.87

u/ml

0.07

359

2708

Other specified/unspecified bacterial intestinal infections

652

4374

1.66

25.35

1.4

1.3

2.34

1.51

u/ml

0.40

129

1148

Septicaemia

3671

29791

1.23

25.32

1.3

1.86

1.83

u/ml

0.06

894

7641

Anosmia

242

1210

2.29

25.27

1.3

1.2

1.62

2.99

u/ml

0.96

323

Ulcer of oesophagus

549

3510

1.70

25.21

1.2

1.13

2.04

u/ml

1.73

133

930

Other disorders of nervous system

617

4088

1.68

25.15

1.3

1.2

1.40

1.56

u/ml

0.10

140

1066

Anogenital herpesviral [herpes simplex] infection

834

5945

1.59

25.01

1.4

1.3

2.16

1.45

u/ml

0.49

186

1741

Memory loss

771

5333

1.57

24.92

1.3

1.2

2.98

1.59

u/ml

0.92

1343

174

3672

0.44

24.87

1.2

2.87

1.96

u/ml

0.56

954

Other and unspecified drugs and medicaments

864

6152

1.55

24.84

1.4

1.3

1.45

u/ml

0.00

229

1646

ILD, hospital admission 2, with pulmonary infections

747

5121

1.57

24.81

1.3

1.2

1.08

1.82

u/ml

2.95

192

1287

Other interstitial pulmonary diseases

1147

8475

1.44

24.78

1.3

1.2

1.07

1.68

u/ml

3.19

291

2093

Cluster headache, wide,, including avohilmo

614

4117

1.70

24.78

1.4

1.3

0.97

1.48

u/ml

1.37

187

1159

Hepatic failure, not elsewhere classified

359

2097

1.98

24.74

1.4

1.2

3.90

1.72

u/ml

0.68

562

Nonsuppurative otitis media

3282

23916

1.25

24.70

1.4

2.43

1.75

u/ml

1.07

779

6380

Interstitial lung disease endpoints

1147

8481

1.44

24.68

1.3

1.2

1.07

1.68

u/ml

3.18

291

2095

Interstitial lung disease

1147

8481

1.44

24.68

1.3

1.2

1.07

1.68

u/ml

3.18

291

2095

Reactive arthropathies, FINNGEN

766

5333

1.58

24.63

1.3

1.81

1.77

u/ml

0.03

183

1403

Chondrocostal junction syndrome [Tietze]

438

2729

1.89

24.60

1.4

1.3

0.95

1.63

u/ml

1.33

119

728

Methotrexate

1553

12061

1.37

24.56

1.3

1.22

1.75

u/ml

1.52

455

3244

Presence of other devices

1868

14748

1.32

24.52

1.3

1.2

2.40

1.87

u/ml

0.73

479

3700

Vasomotor rhinitis (mode)

770

5386

1.59

24.49

1.3

2.15

1.62

u/ml

0.34

230

1447

Eosinophilic disease (BM)

191

916

2.63

24.41

1.5

1.3

0.61

1.55

u/ml

2.06

257

Impotence

404

2412

1.85

24.41

1.4

1.2

2.08

2.58

u/ml

0.33

643

Other diseases of biliary tract

739

5094

1.58

24.33

1.3

1.16

1.69

u/ml

0.94

203

1271

Other septicaemia

3235

26601

1.24

24.28

1.3

1.66

1.88

u/ml

0.46

795

6827

L04AC Interleukin inhibitors

570

3777

1.73

24.26

1.3

1.25

1.54

u/ml

0.22

159

1070

Nontoxic goitre/thyroid nodule

3020

25268

1.25

24.23

1.3

1.10

1.56

u/ml

2.88

774

6546

Other benign neoplasms of skin

3633

30261

1.22

24.02

1.3

1.59

1.63

u/ml

0.08

894

8193

Acute and subacute iridocyclitis

1938

15506

1.32

23.94

1.3

1.75

1.73

u/ml

0.03

586

4232

Other peripheral vertigo

873

6253

1.53

23.90

1.3

1.2

1.48

1.64

u/ml

0.17

193

1621

Cyst of kidney

577

3804

1.67

23.84

1.2

1.32

1.50

u/ml

0.19

115

962

Sacrococcygeal disorders, not elsewhere classified

368

2200

1.96

23.83

1.4

1.2

1.96

1.58

u/ml

0.16

593

Hyperhidrosis

398

2442

1.93

23.80

1.4

1.2

0.99

1.38

u/ml

0.50

103

655

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tissue transglutaminase IgA Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS